Apparatus and methods for valve and tether fixation

Information

  • Patent Grant
  • 11951002
  • Patent Number
    11,951,002
  • Date Filed
    Tuesday, March 23, 2021
    3 years ago
  • Date Issued
    Tuesday, April 9, 2024
    7 months ago
Abstract
A valve and tether fixation mechanism includes an anchor, a tether, and a prosthetic heart valve. The anchor may be for anchoring a prosthetic heart valve in a native heart valve. The tether may have a distal end coupled to the anchor. The tether may extend proximally from the anchor and connect to a tensioning mechanism. The prosthetic valve may be configured to translate along the tether. The valve may have a tether connecting portion configured to allow for adjustment of the tension in the tether and affix the prosthetic valve to the tether at a desired tension.
Description
BACKGROUND

Valvular heart disease, and specifically aortic and mitral valve disease, is a significant health issue in the United States. Valve replacement is one option for treating heart valves diseases. Traditional valve replacement surgery, the orthotopic replacement of a heart valve, is an “open heart” surgical procedure. Briefly, the procedure necessitates a surgical opening of the thorax, initiation of extra-corporeal circulation with a heart-lung machine, stopping and opening the heart, excision and replacement of the diseased valve, and re-starting of the heart. While valve replacement surgery typically carries a 1-4% mortality risk in otherwise healthy persons, a significantly higher morbidity is associated with the procedure, largely due to the necessity for extra-corporeal circulation. Further, open heart surgery is often poorly tolerated in elderly patients. Thus, if the extra-corporeal component of the procedure could be eliminated, morbidities and cost of valve replacement therapies would be significantly reduced.


While replacement of the aortic valve in a transcatheter manner is the subject of intense investigation, lesser attention has been focused on the mitral valve. This is in part reflective of the greater level of complexity associated with the native mitral valve and thus a greater level of difficulty with regard to inserting and anchoring the replacement prosthesis.


Recent developments in the field have provided devices and methods for mitral valve replacement with reduced invasion and risk to the patient. Such devices may include a prosthetic valve disposed within the native valve annulus and held in place with an anchor seated against an exterior surface of the heart near the ventricular apex, and such anchors must be at least a certain size to seat against the heart with adequate security. Methods of implanting such devices therefore typically require providing an intercostal puncture of significant size to accommodate the anchor. Trauma to the patient increases as a function of the diameter of the puncture. Accordingly, methods and devices for anchoring a prosthetic heart valve that avoid the need for an intercostal puncture would improve patient outcomes.


BRIEF SUMMARY

According to a first aspect of the disclosure, a prosthetic heart valve system includes a prosthetic heart valve, an anchor and a tether. The prosthetic heart valve may have an expandable stent and a prosthetic valve assembly disposed within the stent. The prosthetic heart valve may have a prosthetic valve assembly configured to allow blood to flow in a direction from an inflow end of the stent toward an outflow end of the stent and to substantially block blood from flowing from the outflow end of the stent toward the inflow end of the stent. The prosthetic heart valve may include a tether connecting portion. The anchor may be adapted to be disposed on or adjacent an epicardial surface of a heart of a patient. The tether may have a distal end coupled to the anchor and extend proximally from the anchor. The tether may define a protrusion having a width greater than portions of the tether adjacent the protrusion. The prosthetic heart valve may be configured to translate along the tether toward the distal end of the tether, and the protrusion of the tether may be configured to engage the tether connecting portion to prevent proximal movement of the prosthetic heart valve relative to the tether.


According to another embodiment of the disclosure, a prosthetic heart valve system includes a prosthetic heart valve, an anchor and a tether. The prosthetic heart valve may have an expandable stent and a prosthetic valve assembly disposed within the stent. The prosthetic valve assembly may be configured to allow blood to flow in a direction from an inflow end of the stent toward an outflow end of the stent and to substantially block blood from flowing from the outflow end of the stent toward the inflow end of the stent. The prosthetic heart valve may include a tether connecting portion. The anchor may be adapted to be disposed on or adjacent an epicardial surface of a heart of a patient. The tether may have a distal end coupled to the anchor and extend proximally from the anchor. The tether connecting portion may include a stem having a radially expanded condition, a radially collapsed condition, and a barb extending radially inward from the stem. The barb may be configured to pierce the tether upon transition of the stem from the radially expanded condition to the radially collapsed condition.


According to another embodiment of the disclosure, a prosthetic heart valve system includes a prosthetic heart valve, an anchor, a tether clip and a tether. The prosthetic heart valve may have an expandable stent and a prosthetic valve assembly disposed within the stent. The prosthetic valve assembly may be configured to allow blood to flow in a direction from an inflow end of the stent toward an outflow end of the stent and to substantially block blood from flowing from the outflow end of the stent toward the inflow end of the stent. The prosthetic heart valve may include a tether connecting portion. The anchor may be adapted to be disposed on or adjacent an epicardial surface of a heart of a patient. The tether may have a distal end coupled to the tether clip, a proximal end coupled to the tether connecting portion, a first intermediate tether portion looped around the anchor, and a second intermediate tether portion. The second intermediate tether portion may be threaded through an aperture in the tether clip, and the tether clip may be configured to slide along the second intermediate tether portion to adjust a tension of the tether.


According to another embodiment of the disclosure, a method of implanting a prosthetic heart valve includes positioning an anchor adjacent a ventricular wall while a tether is coupled to and extends proximally from the anchor. The prosthetic heart valve may be advanced distally along the tether while the anchor is positioned adjacent the ventricular wall. The prosthetic heart valve may be deployed into a native valve annulus. The tether may be pulled in a proximal direction to tension the tether. The prosthetic heart valve may be fixed to the tether while the tether is tensioned.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is an exploded view of a prosthetic heart valve.



FIG. 2 is an opened and flattened view of an unexpanded inner frame of the prosthetic heart valve of FIG. 1.



FIGS. 3 and 4 are side and bottom views, respectively, of the inner frame of FIG. 2 in an expanded configuration.



FIG. 5 is an opened and flattened view of an unexpanded outer frame of the prosthetic heart valve of FIG. 1.



FIGS. 6 and 7 are side and top views, respectively, of the outer frame of FIG. 5 in an expanded configuration.



FIGS. 8-10 are side, front, and top views, respectively, of an assembly of the inner frame of FIGS. 2-4 and the outer frame of FIGS. 5-7, all in an expanded configuration.



FIG. 11A is a perspective view of an anchor for the prosthetic valve of FIG. 1.



FIG. 11B is an axial view of the anchor of FIG. 11A.



FIG. 12 is a side view of the anchor for the prosthetic valve of FIG. 1 according to another arrangement.



FIG. 13 is a perspective view of the anchor of FIG. 11 in a partially everted state.



FIG. 14 illustrates a trans-jugular insertion of a delivery tube for the anchor of FIG. 11.



FIG. 15 illustrates a trans-femoral insertion of the delivery tube of FIG. 14.



FIG. 16 illustrates the delivery tube of FIGS. 14 and 15 extending through a wall of a heart.



FIGS. 17-20 illustrate the anchor of FIG. 11 in progressive stages of deployment from the delivery tube of FIGS. 14 and 15.



FIGS. 21A and 21B illustrate the delivery tube being retracted from the anchor of FIG. 11.



FIGS. 22-23 are perspective views of a ball and flap mechanism on a tether connecting portion of the valve interacting with a tether in a closed and opened state, respectively.



FIG. 24 is a side view of the ball and flap mechanism on the tether connecting portion while attached to the prosthetic valve.



FIG. 25 is a cross-section of a tabbed valve stem on the tether connecting portion of the prosthetic valve interacting with the tether.



FIGS. 26-27 are opened and flattened views of a barbed valve stem on the tether connecting portion while the prosthetic valve is in a compressed delivery state and an expanded deployed state, respectively.



FIGS. 28-29 are side views of a guy-line tensioner interacting with the tether in an open and closed state, respectively.



FIGS. 30-31 are side views of a clutch mechanism interacting with a knotted tether in a closed and open state, respectively.



FIG. 32 illustrates the valve of FIG. 1 implanted in a heart.





DETAILED DESCRIPTION

As used herein, the term “proximal,” when used in connection with a delivery device or components of a delivery device, refers to the end of the device closer to the user of the device when the device is being used as intended. On the other hand, the term “distal,” when used in connection with a delivery device or components of a delivery device, refers to the end of the device farther away from the user when the device is being used as intended. Further, the term “inflow end” when used herein in connection with a prosthetic atrioventricular valve refers to the end of the prosthetic valve nearest the atrium when the prosthetic valve is implanted in an intended position and orientation, while the term “outflow end” refers to the end of the prosthetic valve nearest the ventricle when the prosthetic valve is implanted in the intended position and orientation. As used herein, the terms “substantially,” “generally,” “approximately,” and “about” are intended to mean that slight deviations from absolute are included within the scope of the term so modified.


An exemplary prosthetic heart valve 110 as may be used with various embodiments of the present disclosure is shown in an exploded view in FIG. 1. Valve 110 includes an inner structure or assembly 112 and an outer structure or assembly 114. Valve 110 may be coupled to a tether 226 and a collapsible tether anchor 210.


Inner assembly 112 may include an inner frame 140, outer wrap 152 which may be cylindrical, and leaflet structure 136 (including articulating leaflets 138 that define a valve function). Leaflet structure 136 may be sewn to inner frame 140, and may use parts of inner frame 140 for this purpose, although methods of attachment other than sutures may be suitable. Inner assembly 112 is disposed and secured within outer assembly 114, as described in more detail below.


Outer assembly 114 includes outer frame 170. Outer frame 170 may also have in various embodiments an outer frame cover of tissue or fabric (not pictured), or may be left without an outer cover to provide exposed wireframe to facilitate in-growth of tissue. Outer frame 170 may also have an articulating collar or cuff (not pictured) covered by a cover 148 of tissue or fabric.


Tether 226 is connected to valve 110 by inner frame 140. Thus, inner frame 140 includes tether connecting or clamping portion 144 by which inner frame 140, and by extension valve 110, is coupled to tether 226.


Inner frame 140 is shown in more detail in FIGS. 2-4. Inner frame 140 can be formed from a milled or laser-cut tube of a shape-memory material such as, for example, nitinol. Inner frame 140 is illustrated in FIG. 2 in an initial state, e.g., as milled or laser-cut, but cut longitudinally and unrolled into a flat sheet for ease of illustration. This initial state may generally correspond to a collapsed condition. Inner frame 140 is shown unconstrained, e.g., to the expanded, deployed configuration, in the side view and bottom view of FIGS. 3 and 4, respectively. Inner frame 140 can be divided into four portions corresponding to functionally different portions of inner frame 140 in final form: apex portion 141, body portion 142, strut portion 143, and tether connecting portion 144. Strut portion 143 includes six struts, such as strut 143A, which connect body portion 142 to connecting portion 144. A greater or fewer number of struts 143A is contemplated herein.


Connecting portion 144 includes longitudinal extensions of the struts 143A, connected circumferentially to one another by pairs of v-shaped connecting members, which may be referred to herein as “micro-V's.” Connecting portion 144 is configured to be radially collapsed by application of a compressive force, which causes the micro-V's to become more deeply V-shaped, with each pair of vertices moving closer together longitudinally and the open ends of the V shapes moving closer together circumferentially. When collapsed, connecting portion 144 can clamp or grip one end of tether 226, either connecting directly onto a tether line (e.g., braided filament line) or onto an intermediate structure, such as a polymer or metal piece that is, in turn, firmly fixed to the tether line. The foregoing is merely exemplary and other techniques can be used to connect tether 226 to connecting portion 144, as will be discussed below in further detail.


In contrast to connecting portion 144, apex portion 141 and body portion 142 are configured to be expanded radially. Strut portion 143 forms a longitudinal connection, and radial transition, between the expanded body portion 142 and the compressed connecting portion 144.


Body portion 142 includes six longitudinal posts, such as post 142A, although the body portion may include a greater or fewer number of such posts. The posts 142A can be used to attach leaflet structure 136 to inner frame 140, and/or can be used to attach inner assembly 112 to outer assembly 114, such as by connecting inner frame 140 to outer frame 170. In the illustrated example, posts 142A include apertures 142B through which connecting members (such as suture filaments and/or wires) can be passed to couple the posts to other structures.


Outer frame 170 of valve 110 is shown in more detail in FIGS. 5-7. Outer frame 170 can be formed from a milled or laser-cut tube of a shape-memory material such as, for example, nitinol. Outer frame 170 is illustrated in FIG. 5 in an initial state, e.g., as milled or laser-cut, but cut longitudinally and unrolled into a flat sheet for ease of illustration. This initial state may generally correspond to the collapsed condition. Outer frame 170 can be divided into a coupling portion 171, a body portion 172, and a flared portion 173, as shown in FIG. 5. Coupling portion 171 may include multiple openings or apertures 171A by which outer frame 170 can be coupled to inner frame 140, as described in greater detail below.


Flared portion 173 may include an indicator 174. In one example, indicator 174 is simply a broader portion of the wire frame element of flared portion 173. Indicator 174 may be more apparent in radiographic or other imaging modalities than the surrounding wireframe elements of flared portion 173. In other examples, indicator 174 can be any distinguishable feature (e.g., protrusion, notch, etc.) and/or indicia (e.g., lines, markings, tic marks, etc.) that enhance the visibility of the part of flared portion 173 on which it is formed, or to which it is attached. Indicator 174 can facilitate the implantation of the prosthetic valve by providing a reference point or landmark that the operator can use to orient and/or position the valve (or any portion of the valve) with respect to the native valve annulus or other heart structure. For example, during implantation, an operator can identify (e.g., using echocardiography) indicator 174 when the valve 110 is situated in a patient's heart. The operator can therefore determine the location and/or orientation of the valve and make adjustments accordingly.


Outer frame 170 is shown in an expanded, deployed configuration, in the side view and top view of FIGS. 6 and 7, respectively. As best seen in FIG. 7, the lower end of coupling portion 171 may form a roughly circular opening (identified by “O” in FIG. 7). The diameter of this opening preferably corresponds approximately to the diameter of body portion 142 of inner frame 140, when the inner frame is in the expanded condition, to facilitate the coupling together of these two components of valve 110.


Outer frame 170 and inner frame 140 are shown coupled together in FIGS. 8-10 in front, side, and top views, respectively. The two frames collectively form a structural support for a valve leaflet structure, such as leaflet structure 136 in FIG. 1. The frames support leaflet structure 136 in the desired relationship to the native valve annulus, support the coverings for the two frames to provide a barrier to blood leakage between the atrium and ventricle, and couple to the tether 226 (by the inner frame 140) to aid in holding the prosthetic valve in place in the native valve annulus by the connection of the free end of the tether and tether anchor 210 to the ventricle wall, as described more fully below. The two frames are connected at six coupling points (representative points are identified as “C”). In this embodiment, the coupling of the frames is implemented with a mechanical fastener, such as a short length of wire, passed through an aperture 171A in coupling portion 171 of outer frame 170 and a corresponding aperture 142B in a longitudinal post 142A in body portion 142 of inner frame 140. Inner frame 140 is thus disposed within the outer frame 170 and securely coupled to it.


An exemplary anchor 210 for a prosthetic mitral heart valve is illustrated in FIGS. 11A and 11B. Anchor 210 includes a first disc 214 and a second disc 218, both provided by a wire mesh and centered on an axis X. First disc 214 is offset from second disc 218 in a first direction along axis X. First disc 214 and second disc 218 are each biased toward a dome-shaped resting configuration that is concave toward a second direction along axis X, the second direction being opposite the first direction. The resting configuration of first disc 214 extends far enough in the second direction along axis X to partially overlap second disc 218.


It should be understood that the illustrated dome shapes are merely exemplary, and first disc 214 and second disc 218 may be biased differently. For example, either or both of first disc 214 and second disc 218 may be biased toward a resting configuration that is convex toward the second direction or generally planar. Further, the first disc 214 and second disc 218 may be biased to different resting configurations. In one example, the first disc 214 may be biased toward a dome-shaped resting configuration that is concave toward the second direction while the second disc 218 is biased toward a generally planar configuration having about the same diameter location as the widest part of the dome-shaped resting configuration of the first disc 214, as shown in FIG. 12. In the arrangement shown in FIG. 12, second disc 218 is generally planar in shape with a shallow concavity toward the first direction near the center of second disc 218.


Anchor 210 may also include a cuff 222 for gripping a tether 226, which may be connected to a prosthetic heart valve. Cuff 222 is offset from second disc 218 in the second direction along axis X. One-way gripping features, such as angled teeth, within cuff 222 may permit anchor 210 to slide along tether 226 in the second direction, but not the first direction. In other embodiments, cuff 222 may be fixedly attached to tether 226 so that the anchor 210 may not slide along the tether.


Anchor 210 is flexible, as illustrated in FIG. 13, which shows anchor 210 with the first disc 214 everted from its resting configuration. First disc 214 is connected to second disc 218 by a neck 228 extending between first disc 214 and second disc 218. In the illustrated example, neck 228 is centered on axis X, but in other examples neck 228 may be radially offset from axis X. First disc 214, second disc 218, and neck 228 may all be constructed from a single continuous piece or tube of wire mesh. The wire mesh may be formed from a plurality of strands or wires braided into various three-dimensional shapes and/or geometries to engage tissues, or from one or more sheets cut to provide mesh, such as by laser. In one example, the wires form a braided metal fabric that is resilient, collapsible and capable of heat treatment to substantially set a desired shape. One class of materials which meets these qualifications is shape-memory alloys, such as nitinol. The wires may comprise various materials other than nitinol that have elastic and/or memory properties, such as spring stainless steel, tradenamed alloys such as Elgiloy® and Hastelloy®, CoCrNi alloys (e.g., tradename Phynox), MP35N®, CoCrMo alloys, or a mixture of metal and polymer fibers. Depending on the individual material selected, the strand diameter, number of strands, and pitch may be altered to achieve the desired shape and properties of anchor 210. Shape memory materials such as nitinol may be particularly suitable for anchor 210 in that shape memory material construction enables anchor 210 to consistently return to an intended shape after being compressed and deployed. In other arrangements, anchor 210 may be covered by or may incorporate other flexible biocompatible material, such as a fabric. Although anchor 210 is one example of an expandable anchor that may be suitable for use with the prosthetic valves of the present disclosure, it should be understood that other anchors, including other expandable anchors, may also be suitable.



FIG. 14 shows a trans-jugular insertion of an at least partially flexible delivery tube 230 for anchor 210 and valve 110. Delivery tube 230 may be formed of any known material for building catheters, including biocompatible metals such as steel, and may be part of a steerable or flexible catheter system. Delivery tube 230 may include an inflexible portion near its distal end to facilitate the intended puncture of tissue and guidance of valve 110. Delivery tube 230 is inserted through the patient's jugular vein (not shown), then through superior vena cava 236, right atrium 252, atrial septum 254, left atrium 256, native mitral valve 260, and into left ventricle 242. Tube 230 exits left ventricle 242 through ventricular wall 238 at or near the apex 246 of heart 234. A retractable puncturing device (not shown) and a retractable atraumatic tip (not shown) may extend from the distal open end 248 of tube 230 in alternate stages of insertion of tube 230. The puncturing device may produce openings through atrial septum 254 and ventricular wall 238 while the atraumatic tip may act to prevent injury to other tissue. Once delivery tube 230 has been fully inserted, the distal open end 248 of tube 230 is positioned outside of ventricular wall 238. The trans-jugular insertion of tube 230 may be accomplished by any of variety of methods, such as, for example, guiding tube 230 along a guide wire, such as a shape-memory guide wire, inserted through the jugular vein. The flexible nature of anchor 210 allows trans-jugular delivery of anchor 210 through tube 230. Because tube 230, anchor 210, and valve 110 all reach heart 234 from the jugular vein, valve 110 and anchor 210 may be delivered and implanted without any intercostal puncture.



FIG. 15 shows a trans-femoral insertion of tube 230. Tube 230 enters heart 234 through inferior vena cava 250, travels through right atrium 252, and punctures septum 254 to enter left atrium 256. Tube 230 is advanced from left atrium 256 through native mitral valve 260, left ventricle 242, and ventricular wall 238 such that the open end 248 of the tube is positioned outside of wall 238 at or near apex 246. As with trans-jugular insertion, guidance of tube 230 during trans-femoral insertion may be accomplished using a variety of methods, including guidance along a guide wire.


The trans-jugular and trans-femoral insertions described above are merely exemplary. It should be understood that tube 230 could be guided toward heart 234 using any suitable method known in the art.



FIGS. 16-20 illustrate anchor 210 in progressive stages of deployment from the open end 248 of tube 230. Tube 230 is shown in a distalmost position in FIG. 16, with open end 248 positioned outside of heart 234. Tube 230 may be retracted while anchor 210 is forced to remain in place, such as by a reversal of a typical Bowden cable arrangement. For example, a semi-rigid cable or wire 266 may be inserted through tube 230 to contact the proximal end of anchor 210, as shown in FIG. 21A. Pulling tube 230 proximally relative to wire 266 causes anchor 210 to deploy out from the open end 248 of tube 230, as shown in 21B. As shown in FIG. 17, retracting tube 230 while preventing anchor 210 from retreating with the tube into heart 234 causes first disc 214 of anchor 210 to deploy out from the open end 248 of tube 230 and expand radially relative to axis X. Upon further retraction of tube 230, the bias of first disc 214 causes it to curve back onto the outer apex 246 of heart 234, as shown in FIG. 18. Further retraction of tube 230 in FIG. 19 allows second disc 218 to deploy and expand radially relative to axis X within left ventricle 242 until second disc 218 opens to press against an inner side of wall 238, as shown in FIG. 20. Pressure against wall 238 results from the elastic bias of first disc 214 and second disc 218 toward certain resting positions as described above with regard to FIGS. 11A, 11B, and 12. First disc 214 and second disc 218 pressing on opposite sides of wall 238 causes anchor 210 to grip wall 238. Such progressive expansion from within a narrow tube results in anchor 210 adequately securing valve 110 to ventricular wall 238 without requiring an intercostal puncture through the patient's chest.


In the trans-jugular and trans-femoral delivery routes described above, one end of the tether 226 is preferably fixed to the anchor 210 before deployment of the anchor 210, including prior to loading the valve 110 into tube 230. Tether 226 and anchor 210 remain attached while anchor 210 is delivered to the exterior of ventricular wall 238 from within tube 230, and tether 226 is uncovered by the retraction of tube 230. In alternate embodiments, the anchor 210 and tether 226 may be fixed to one another during or immediately after deployment of the anchor 210. The tether 226 may extend proximally to a second free end, and the prosthetic valve 110 is preferably delivered over the tether 226, using the tether 226 as a rail and/or guide, with the tether 226 extending through a center portion of prosthetic valve 110 while the valve 110 is being delivered to the native valve annulus. Once the prosthetic valve 110 is at or adjacent the final position within the native valve annulus, the prosthetic valve 110 is preferably fixed to the tether 226 by engagement or activation of the tether connecting portion 144 with the tether 226. This engagement may be accomplished via one or more mechanisms, including those described below, and the engagement may occur just before, during, or just after deployment of the prosthetic valve 110. Much of the below disclosure relates to a further embodiment of tether connecting portion 144 to facilitate such a connection between the prosthetic valve 110 and the second end of the tether 226. Placement of valve 110 into native mitral valve 260 may involve affixing tether 226 to anchor 210 at one end of tether 226, as noted above. It may also involve affixing tether 226 to a tensioning mechanism (not shown) at the other end of tether 226. The tensioning mechanism may include a load sensor for measuring tension and will remain outside the body of the patient while anchor 210 is inserted through one of the above-mentioned methods. Although it should be understood that the tensioning mechanism may be affixed to the tether after the anchor 210 is deployed. Thus, after anchor 210 is secured against outer apex 246 of heart 234, tether 226 may extend from anchor 210 to the tensioning mechanism, e.g., the entire length of the path used to insert anchor 210 against outer apex 246. One example using an above-mentioned method may embody tether 226 extending from anchor 210 through ventricular wall 238, left ventricle 242, native mitral valve 260, left atrium 256, atrial septum 254, right atrium 252, superior vena cava 236, exiting the patient through a jugular vein (not shown) and attaching to the tensioning mechanism outside the patient. Maintenance of tether 226 in this position may permit valve 110 to attach to tether 226 outside the patient's body, using tether 226 as a guide to follow the path of tether 226 to place valve 110 within native mitral valve 260. Several embodiments of how valve 110 may be secured into place in native mitral valve 260 will be explained below in further detail. It should be understood that, if the prosthetic valve 110 is fixed to the tether 226 after the anchor 210 is deployed and the prosthetic valve 110 is at or near its final desired position, it may be preferable to fix the prosthetic valve 110 to the tether 226 by activating or engaging the tether connecting portion 144 to the tether 226 after the tether 226 has been tensioned a desired amount, at which point the coupling of the tether connecting portion 144 of the prosthetic valve 110 to the tether 226 will maintain the desired tension in the tether 226. Such tension may provide certain benefits, for example helping to prevent the prosthetic valve 110 from migrating into the atrium. The force on the ventricle from the tension of the tether 226 may also facilitate more efficient functioning of the ventricle. Various mechanisms for fixing the prosthetic valve 110 to the tether 226 after the tether 226 has been tensioned are described in greater detail below.



FIGS. 22-24 show an embodiment of a tether connecting mechanism 300 for coupling a prosthetic heart valve similar to valve 110 to a tether 326 similar to tether 226. In the illustrated embodiment, tether connecting mechanism 300 takes the form of a ball and flap mechanism 300. The ball and flap mechanism 300 may function to secure valve 110 in native mitral valve 260 with desired tension on tether 326. Ball and flap mechanism 300 may be attached to strut portion 143 of valve 110 on the end of valve 110 nearest anchor 210, i.e. the outflow end, as shown in FIG. 24. In other words, the ball and flap mechanism 300 may either replace the tether connecting portion 144 of inner frame 140, or may be positioned within the tether connecting portion 144 of inner frame 140. Tether 326 may be substantially similar or identical to tether 226, with at least one exception. For example, at least a portion of tether 326 may include balls 308, or other protrusions or enlarged-width structures, spaced from one another along the length of tether 326. In one embodiment, the balls 308 are only positioned along the portion of tether 326 that is expected to engage the ball and flap mechanism 300. As is described in greater detail below, the balls 308 facilitate connection between the tether 326 and the prosthetic valve 110, as well as facilitating the maintenance of a desired tension on the tether 326. Tether 326 is not limited to the use of balls 308; other examples may include knots, beads, other clamp-on pieces, etc. Ball and flap mechanism 300 may include a flap 304 hingedly coupled to valve stem body 302, for example by hinge 306. Flap 304 may be in a closed position when flap 304 sits generally perpendicular to a central longitudinal axis of valve stem body 302, as shown in FIG. 22. Flap 304 may be in an open position when flap 304 sits generally parallel to the longitudinal axis of valve stem body 302 as shown in FIG. 23. In some embodiments, flap 304 may be biased into a closed position by a biasing member, for example a torsion spring (not shown). In the illustrated embodiment, flap 304 has a free end 360 generally opposite the end 370 where hinge 306 couples the flap 304 to the valve stem body 302. The free end of the flap 304 may have a generally circular circumference 330 that is interrupted by a substantially “U”-shaped recessed portion 340, with two free arms 350a, 350b of the flap defining portions of the “U”-shaped recess. The recessed portion may be adapted to receive a portion of tether 326 therethrough, as shown in FIG. 22. The “U”-shaped recessed portion may have a width defined between inner edges 350c of the two free arms, the width of the recessed portion being greater than a diameter DT of the tether 326, but smaller than a diameter DB of the balls 308.


As noted above, after the anchor 210 has been deployed, the prosthetic valve 110 may be guided over the tether 326 toward the mitral valve 260, for example, while collapsed in a sheath of a delivery device, with the delivery device sheath and the prosthetic valve 110 being fed over the tether 326. During this delivery, the tether 326 may be held taut, for example manually or via a tensioning mechanism coupled to the tether 326. During delivery, the valve stem body 302 may be the leading end of the prosthetic valve 110. As the valve stem body 302 approaches and slides over the balls 308 of the tether 326, the first encountered ball 308 may cause the flap 304 to open. If the flap 304 is biased toward the closed condition, it will begin to close as soon as the recessed portion of the flap 304 clears the ball 308. The flap 304 may be biased toward the closed condition by a torsion spring. Alternatively, the flap 304 may be coupled to the tether 326 such that the tension in the tether 326 may bias the flap 304 toward the closed condition. As the prosthetic valve 110 continues to approach the native mitral valve 260, the flap 304 may continue opening and closing as it passes successive balls 308 on the tether 326. The prosthetic valve 110 is advanced until it reaches the desired position within the native mitral valve 260. It should be understood that, depending on the position of the balls 308 on tether 326, the prosthetic valve 110 may reach the desired position in the native mitral valve 260 without encountering any of the balls 308. Maintaining a level of tension on the tether 326 while the prosthetic valve 110 is being advanced distally over the tether 326 may help ensure that the flap 304 does not cause the tether 326 to be pushed distally, but rather the balls 308 of the tether 326 cause the flap to open upon contact between the flap 304 and ball 308.


After prosthetic valve 110 has reached the desired position in native mitral valve 260, the prosthetic valve may be ejected from the delivery device and expand (for example via self-expansion or balloon expansion) into the annulus of the native mitral valve 260. Once the position and/or orientation of the prosthetic valve 110 is confirmed as desired, the tether 326 may be tensioned. Tensioning the tether 326 may include pulling the tether 326 proximally, for example manually or via a tensioning tool coupled to the free end of the tether 326. In some embodiments, the tensioning tool may grip a portion of the tether 326, with a portion of the tensioning tool being rotated or otherwise activated to pull the tether 326, preferably with a measurement of the tension being measured during the process, for example via a load cell. As the tether 326 is tensioned, the pulling/tensioning force causes tether 326 and associated balls 308 to translate proximally relative to the valve stem body 302 of prosthetic valve 110 while the prosthetic valve 110 is held in place in native mitral valve 260. As each ball 308 passes proximally through valve stem body 302, and the relatively large diameter of the ball 308 is unable to pass through the recessed portion of flap 304, resulting in the flap 304 moving into the open position, with hinge 306 facilitating flap 304 moving into the open position. While the flap 304 is in the open position, the ball 308 is permitted to pass proximally through ball and flap mechanism 300 as demonstrated in FIG. 23. After a ball 308 clears flap 304, flap 304 may return to a closed position, for example via the biasing force of the hinge 306. While flap 304 sits in the closed position, flap 304 does not permit ball 308 to pass distally through the recessed portion of flap 304 or valve stem body 302. This may be accomplished, for example, via a rim, shoulder or ledge in the proximal end of valve stem body 302 defined by a valve stem body 302 opening that is smaller than the outer circumferences of the flap 304, so that an outer edge portion of flap 304 abuts the rim of the proximal end of the valve stem body 302 in the closed condition. The tether 326 may be continued to be pulled proximally to further tension the tether 326 until a desired tension on tether 326 is achieved between anchor 210 and valve 110. The level of desired tension may be determined via any suitable method, including for example a display on the tensioning mechanism that outputs a tension force as the tether 326 is tensioned.


While the tether 326 is being tensioned, the contact between the balls 308 and the flap 304 may tend to pull the valve stem body 302, and the connected prosthetic valve 110, proximally in the direction that the tether 326 is being pulled. In some embodiments, the flap 304 may move freely enough that pulling the tether 326 does not tend to move the prosthetic valve 110. For example, the frictional force between the expansion of the prosthetic valve 110 and the annulus of the native mitral valve 260 may be large enough to ensure that the force of the balls 308 pulling against flap 304 does not tend to move the prosthetic valve 110 in the direction that the tether 326 is being pulled. In other embodiments, a separate tool may be provided, for example as part of the delivery system, to contact the prosthetic valve 110 to provide a counteracting force to maintain the prosthetic valve 110 in the desired position as the tether 326 is pulled proximally. Once the tether 326 reaches the desired tension, tension on the tether 326 may be released, causing the tether 326 to tend to move distally through the valve stem body 302. However, as noted above, the balls 308 of the tether 326 are unable to pass through the flap 304 in the distal direction since the flap 304 is in abutment with the proximal end of the valve stem body 302. Thus, the contact between one of the balls 308 and the proximal face of flap 304 may result in tension being maintained and the flap 304 being maintained in the closed condition, particularly if the flap 304 is not actively biased toward the closed condition.


If it is determined that the tension on the tether 326 is too large, the tension may be relieved by any suitable mechanism. For example, a tool may be introduced via the delivery device (or a separate delivery device) to a position adjacent the valve stem body 302, and the tool may be used to pull or otherwise hold flap 304 in the open position to allow balls 308 and tether 326 to pass distally through ball and flap mechanism 300 in order to reintroduce slack (or otherwise reduce tension) in tether 326 between valve 110 and anchor 210. Whether or not the tension is readjusted in this manner, once the tension is at the final desired level and the tether 326 does not need to be further adjusted with respect to the ball and flap mechanism 300, excess length of the tether proximal to the flap 304 may be removed by any suitable mechanism. For example, a tool may be utilized to cut the excess length of tether 326 extending proximally from valve 110 via cautery or mechanical cutting, with the entire length of the tether 326 proximal to the position of the cut to be removed from the patient.



FIG. 25 shows a tabbed valve stem 400, which may provide similar functionality as the ball and flap mechanism 300 described above. In the illustrated embodiment, tabbed valve stem 400 may be substantially similar to connecting portion 144 described above, with certain exceptions. For example, tabbed valve stem 400 can be formed from a milled or laser-cut tube of a shape-memory material such as, for example, nitinol, similar or identical to that described above in connection with connecting portion 144. Tabbed valve stem 400 may form a substantially cylindrical structure, and may include the micro-V's described above in connection with connecting portion 144, or similar structures. However, while connecting portion 144 may form an entirely cylindrical passageway therethrough, tabbed valve stem 400 may include structures extending into the interior passage of the tabbed valve stem 400. In the view of FIG. 25, a cross-section of the tabbed valve stem 400 is illustrated with tether 426 passing therethrough. In the orientation of FIG. 25, the bottom of the tabbed valve stem 400 represents the outflow end of the prosthetic valve, while the remainder of the inner frame 140, which would extend from the top of the tabbed valve stem 400, is omitted from the drawing. The other components of the prosthetic valve, such as the outer frame 170, are also omitted from the figure for purposes of clarity. Tabs 402 may be laser cut into the nitinol tube portion 404 of tabbed valve stem 400. For example, tabs 402 may be substantially “V”-shaped similar to the micro-V's described above. In the illustrated embodiment, tabs 402 are shaped so that the apex of the “V”-shape is pointed substantially in the proximal direction (toward the top of the page in the view of FIG. 25) while the opposite end of the “V”-shape is pointed substantially in the distal direction (toward the bottom of the page in the view of FIG. 25). In other words, the tabs 402 may be formed integrally with tubing 404, although in other embodiments, the tabs 402 may be formed separately and attached to tubing 404. Although a substantial “V”-shape is described, other shapes may be suitable, including linear bar shapes, or any other suitable shape. The tabs 402 may each be shape set such that, in the absence of applied forces, tabs 402 form an angle transverse to tubing 404. While in this shape set condition, the ends of tabs 402 facing radially inward may point in a generally proximal direction, while the ends of tabs 402 facing radially outward may point in a generally distal direction. Tabbed valve system 400 may function in a similar fashion to ball and flap mechanism 300 described above. For example, tether 426 may be similar or identical to tether 326 and may similarly include balls 408 spaced along tether 426. The delivery of the prosthetic valve 110 may be substantially identical as described above in connection with ball and flap mechanism 300. For example, when tension is applied to the tether 426 by pulling the tether 426 proximally, tabs 402 may pivot about their connection to tubing 404 to separate, permitting balls 408 to pass beyond the tabs 402. In one example, the tabs 402 may be pivotably connected to tubing 404 at a point nearer the distal end of the tabs 402 than the proximal end of the tabs 402. When in the set shape, in the absence of applied forces, the distance between the proximal ends of the tabs 402 may be smaller than the diameter of the balls 408, but larger than the diameter of the portions of tether 426 between adjacent balls 408. Thus, as the tether 426 moves proximally relative to the tabs 402, the balls 408 will cause the tabs 408 to separate. After ball 408 has completely cleared or passed tabs 402, tabs 402 may return to a resting position, for example against tether 426. When the pulling force on tether 426 is released, and the tether 426 is tensioned, the tether 426 will tend to try to move distally with respect to tabs 402 to release the tension. However, due to their set shape, the tabs 402 will not permit balls 408 to move distally past tabs 402. Proximal pulling of the tether 426 may continue until a desired tension on tether 426 is reached between anchor 210 and valve 110. Then, upon releasing the tether 426, the tabs 402 will maintain the tether 426 in or near the desired tension by preventing distal movement of the tether 426 relative to the tabs 402. The ends of tabs 402 facing radially outward (or generally distally) may extend radially beyond the outer perimeter of the tubing 404, such that the outward ends of tabs 402 may be compressed to force tabs 402 to pivot into the substantially open position in order to allow balls 408 to translate distally through tubing 400 to reintroduce slack in tether 426 between valve 110 and anchor 210. A tool may be utilized to cut excess tether 426 extending proximally from valve 110 via cautery or mechanical cutting, with the entire length of the tether 426 proximal to the position of the cut to be removed from the patient.



FIGS. 26-27 show a barbed valve stem 500, which may be provided on prosthetic valve 110 as an alternate embodiment of tether connecting portion 144. Although the remainder of prosthetic heart valve 110 is omitted from FIGS. 26-27, it should be understood that barbed valve stem 500 is positioned at or near the outflow end of the prosthetic valve 110 (toward the bottom in the view of FIGS. 26-27), while the remainder of the valve would be positioned above the barbed valve stem 500 in the view of FIGS. 26-27. Barbed valve stem 500 can be formed from a milled or laser-cut tube of a shape-memory material such as, for example, nitinol. Preferably, barbed valve stem 500 is formed integrally with the inner frame 140, although in some embodiments, the barbed valve stem 500 may be formed separately and attached to inner frame 140. Barbed valve stem 500 may be cut into diamond cells that allow it to compress and expand, for example via self-expansion via shape-memory material properties or via mechanical compression or expansion via a suitable mechanical device.


Barbed valve stem is shown in FIGS. 26-27 as if unrolled into a flat sheet for ease of illustration, although it should be understood that, in practice, the barbed valve stem 500 is generally tubular. In FIG. 26, barbed valve stem 500 is illustrated in an axially collapsed, radially expanded condition. This condition may also correspond to the delivery condition of the prosthetic valve 110. It should be noted that, although the barbed valve stem 500 is in an axially collapsed, radially expanded condition during delivery, the remainder of the prosthetic valve 110 is in an axially expanded, radially collapsed condition during delivery. Even when the barbed valve stem 500 is in a radially expanded condition, the diameter or profile of the barbed valve stem 500 is smaller than the diameter of the remainder of the prosthetic valve 110 while the remainder of the prosthetic valve 110 is in the radially collapsed condition. As a result, maintaining the barbed valve stem 500 in a radially expanded condition during delivery does not negatively affect the overall delivery profile of the prosthetic valve 110. Barbed valve stem 500 may be shape set as to tend to transition to the radially collapsed condition shown in FIG. 27. Thus, the barbed valve stem 500 may need to be maintained or held in the radially expanded condition during delivery of the prosthetic valve 110. One mechanism by which the barbed valve stem 500 may be maintained in the radially expanded condition (or the axially collapsed condition) is at least one suture loop 504 which may loop around points of barbed valve stem 500 and extend proximally to be accessible to a surgeon. In the illustrated example, barbed valve stem 500 is maintained in the radially expanded condition by three suture loops 504, with each suture loop having two free ends that extend through the delivery system. For example, each suture loop 504 may have a middle portion that loops one or more times around apices of diamond-shaped cells to axially compress those cells. In one example, each suture loop may loop through a distal-most and proximal-most cell in the barbed valve stem 500. The suture loops 504 may be forced into a relatively small loop circumference in order to draw the cells closer together, and thus maintain the barbed valve stem 500 in the axially compressed (and radially expanded) condition. The barbed valve stem 500 may include a plurality of barbs 502 that have a first end connected to the barbed valve stem 500 and a second free end opposite the first end. The second free end of the barbs 502 may be sharp or pointed in order to allow the barbs 502 to pierce the tether. In the illustrated embodiment, each barb 502 is connected to the barbed valve stem 500 at intersections of adjacent cells. The barbs 502 are preferably integral with the barbed valve stem 500, for example via laser cutting the entire barbed valve stem 500, including barbs 502, from a tube of nitinol or other suitable metal. The barbs 502 are also preferably shape set so that, in the absence of applied forces, they tend to point radially inwardly and proximally. With this configuration, a tether may be able to slide proximally relative to the barbed valve stem 500, even when the barbs 502 are in contact with the tether. However, the barbs 502 may engage and/or pierce the tether when the tether tries to slide distally relative to the barbed valve stem 500 when the barbs 502 are in contact with the tether. Alternatively, barbed valve stem 500 may fixedly attach to the tether when the barbed valve stem 500 is radially compressed and the barbs 502 engage or pierce the tether, such contact between the barbs 502 and the tether prohibiting the prosthetic valve 110 from translating in either direction relative to the tether. When forced into the axially compressed state, the diameter of barbed valve stem 500 may increase, resulting in the sharp free ends of the barbs 502 being spaced apart from the tether. Thus, in this axially compressed condition, a tether passing through the barbed valve stem 500 will not contact (or will not significantly contact) the barbs 502 enough to cause the barbs 502 to engage or pierce the tether. This allows the tether to translate proximally or distally relative to the barbed valve stem 500 when the barbed valve stem 500 is in the radially expanded condition without the barbs 502 significantly hindering such movement.


Barbed valve stem 500 is shown in an axially expanded, radially collapsed, deployed condition in the flattened view of FIG. 27. As noted above, barbed valve stem 500 may be at rest (or have its set shape) when in the radially collapsed state, and may have an inner diameter smaller than (or about equal to) that of the outer diameter of tether to bring the second free ends of the barbs 502 into contact with the tether. During delivery, the suture loops 504 may remain in place (and maintain the barbed valve stem 500 in the radially expanded condition) until prosthetic valve 110 has been positioned at the desired location within the native mitral valve annulus and the desired tension of the tether between anchor 210 and prosthetic valve 110 has been achieved. With the prosthetic valve 110 otherwise in its final desired condition, the suture loop(s) 504 may be released, allowing the barbed valve stem 500 to axially expand and radially collapse, bringing the sharp ends of the barbs 502 into contact with the tether. The suture loops 504 may be released by releasing the grip on one of the free ends of the suture loops 504, and pulling the other free end of the suture loop 504 proximally. As the one free end of the suture loop 504 is pulled, the other free end of the suture loop 504 travels toward the barbed valve stem 500, causing the loops or turns around the cells of the barbed valve stem 500 to unravel or uncoil, and eventually the released free end of the suture loop 504 will pull back through the delivery device and outside of the patient. After the suture loops 504 are released and the barbed valve stem 500 radially collapses, the pulling force on the tether that maintains the tether in the tensioned condition may be released. Upon release of that pulling force, the tether will tend to try to translate distally with respect to the barbed valve stem 500 to release the tension. However, because the sharp ends of the barbs 502 are in contact with the tether, the barbs will engage or pierce the tether (which may be formed of a relatively soft fabric and/or polymer) preventing the tether from translating any significant distance in the distal direction. While the barbs 502 engage the tether, the tension on the tether is maintained at or near the desired level, and the tether is prevented from translating distally relative to the prosthetic valve 110. If it becomes necessary to release the barbs 502 from the tether, for example to re-position or remove the prosthetic valve 110, a tool may be introduced to axially compress barbed valve stem 500 to force the barbed valve stem 500 to radially expand, moving the barbs 502 out of engagement with the tether.



FIGS. 28-29 show guy-line tensioner 600, which may be used with prosthetic valve 110, either in addition to tether connecting portion 144, or an alternate embodiment of tether connecting portion 144. Guy-line tensioner 600 may include a tether 626 that is fixed to prosthetic valve 110 at or near the outflow end of the prosthetic valve 110. For example, a first end of the tether 626 may be fixed to tether connecting portion 144 or to a similar structure. The tether 626 may be threaded through a tension clip 602, for example through a first hole or aperture in the tension clip 602. In one embodiment, the tension clip 602 has a substantially rectangular or oval shape, although other shapes may be suitable. The tension clip 602 may include relatively large front and back faces, with a first aperture extending through the tension clip 602 from the front face to the back face near a first end of the tension clip 602. The tension clip 602 may include a second aperture extending through the tension clip 602 from the front face to the back face near a second end of the tension clip 602 opposite the first end. After the tether 626 passes through the first aperture, it may then loop around pad pulley 610, with the second end 606 of the tether 626 fixed to tension clip 602. Tension clip 602 may be configured such that when tension clip 602 is substantially parallel to a longitudinal axis of the prosthetic valve 110, a relatively large amount of friction exists between tether 626 and tension clip 602, the friction being large enough to prevent translation of tether 626 through tension clip 602. This is the condition illustrated in FIG. 29.


As shown in FIG. 28, tension clip 602 may also be configured to be lifted and/or adjusted by one or more suture loops 604 such that tension clip 602 is no longer substantially parallel to the longitudinal axis of the prosthetic valve 110. Each suture loop 604 may have two free ends and a middle portion therebetween, with the middle portion wrapping or looping around a corresponding aperture or other loop-receiving structure in tension clip 602. As is described in greater detail below, as the tension clip 602 is adjusted from the position shown in FIG. 29 toward the position shown in FIG. 28, friction between the tether 626 and the tension clip 602 reduces, allowing for the tension clip 602 to translate toward the prosthetic valve 110, or alternatively allowing the prosthetic valve 110 to translate toward the tension clip 602. Thus, with tension clip 602 in an adjusted position, friction may decrease between tether 626 and tension clip 602, allowing tether 626 to translate through tension clip 602 to modify tension on tether 626. In the illustrated embodiment, guy-line tensioner 600 includes a first suture loop 604 for adjusting the orientation of tension clip 602 to modify the friction between the tension clip 602 and the tether 626, and a second suture loop 604 for translating the tension clip 602 along tether 626 for increasing or decreasing tension in the tether. Tension in the tether 626 may be sufficient to translate the tension clip 602 without any manipulation of the second suture loop 604 when the tension clip 602 is in an adjusted position. For example, modifying the tension clip 602 from its resting position to an adjusted position may release tension in the tether 626, and tension on the second suture loop 604 may be exerted to preserve a desired level of tension on the tether 626. In order to assist in changing the orientation of the tension clip 602, the suture loop 604 for adjusting orientation is preferably connected to the tension clip 602 near where the second end 606 of the tether 626 couples to the tension clip 602. In order to assist in translating the tension clip 602 to modify the tension of the tether 626, the suture loop 604 for modifying tension is preferably connected to the tension clip 602 close to where the tether 626 passes through the tension clip 602.


Anchor 210 may be deployed around the exterior surface of ventricular wall 238, in a fashion similar or identical to the a method described above, with the tether 626 already passing through the tension clip 602, wrapping around the pad pulley 610, and the second end 606 of the tether 626 already affixed to the tension clip 602. The pad pulley 610 may take the form of a rotatable pulley structure, or a static low friction surface around which the tether 626 wraps or loops. The pad pulley 610 functions to serve as an anchor point for the tether 626 while allowing (or at least not inhibiting) movement of the tether 626 during tension modification. The suture loops 604 may also be attached to the tension clip 602 prior to delivery and remain in place until the anchor 210 and the prosthetic valve 110 have both been deployed. Upon initial deployment of the prosthetic valve 110, the tension clip 602 may be positioned with respect to tether 626 so that the tether 626 has enough slack to ensure that the prosthetic valve 110 is able to be positioned within the native valve annulus while the anchor 210 is deployed. After the initial deployment of the prosthetic valve 110 and the confirmation of the desired positioning, the tether 626 may be tensioned to the desired amount. In order to tension the tether 626, the suture loop 604 for adjusting the orientation of the tension clip 602 may be pulled proximally, transitioning the tension clip 602 from the orientation shown in FIG. 29 to the orientation shown in FIG. 28. As noted above, when tension clip 602 is angled at or near orthogonal to the longitudinal axis of the prosthetic valve 110 (as shown in FIG. 28), friction between the tether 626 and the tension clip 602 where the tether 626 passes through the tension clip 602 is reduced compared to when the tension clip 602 is substantially parallel to the longitudinal axis of the prosthetic valve 110. While the orientation of the tension clip 602 is maintained in the orientation shown in FIG. 28, the other suture loop 604, which is connected to the tension clip 602 near where the tether 626 passes through the tension clip 602, may be pulled proximally. Proximal pulling of this suture loop 604 will tend to draw the tension clip 602 toward the prosthetic valve 110. Since both ends of the tether 626 are fixed, as the tension clip 602 translates toward the prosthetic valve 110, tension on the tether 626 increases. Once the desired tension of tether 626 between anchor 210 and valve 110 has been achieved, the suture loops 604 connected to tension clip 602 near the second end 606 of the tether 626 may be released, allowing the tension clip to again change orientation, from the orientation shown in FIG. 28 to the orientation shown in FIG. 29. In the orientation of FIG. 29, the friction between tether 626 and tension clip 602 increases, such that the force due to friction is larger than the force due to tension, resulting in the tension clip 602 maintaining its position so that the tether 626 remains at the desired tension. Then, the other suture loop 604 may also be released, for example by pulling one end of suture loop 604 proximally until it vacates the patient's body. After both suture loops 604 are released and withdrawn from the patient's body, as shown in FIG. 29, tension clip 602 is in a resting position where tension clip 602 is substantially parallel to the longitudinal axis of prosthetic valve 110, preventing tether 626 from translating through tension clip 602 while maintaining a consistent distance with desired tension in tether 626 between valve 110 and anchor 210.



FIGS. 31-32 show a clutch mechanism 700, an alternative mechanism for securing a tether at a desired tension. The clutch mechanism 700 could be provided within (or adjacent to) tether connecting portion 144 of inner frame 140, or as an alternative to tether connecting portion 144. Clutch mechanism 700 may be substantially similar in function to butterfly clutch pin backs. Clutch mechanism 700 may include a substantially flat, annular base 712 that defines an opening through which tether 726 is configured to pass. When the tether 726 passes through the annular base 712 of the clutch mechanism 700, the base 712 circumscribes tether 726. The clutch mechanism 700 may include plates 706 extending in the outflow direction from the annular base 712 of clutch mechanism 700. When there is no force applied to the plates 706, the plates 706 may have free ends that point radially inwardly toward tether 726. Each respective plate 706 may be operably coupled, for example via a hinge, to a corresponding wing 702. Each wing 702 may extend in the inflow direction from the annular base 712 of clutch mechanism 700. Each wing 702 may be operably coupled to its respective plate 706 such that movement of wings 702 causes corresponding movement of plates 706. Tether 726 may include balls 708 spaced along tether 726 similar or identical to embodiments described above. Plates 706 may be positioned such that, in a resting state, the distance between plates 706 at their free ends is less than the diameter of ball 708, but greater than or equal to the diameter of the portions of tether 726 between adjacent balls 708, preventing tether 726 from translating through clutch mechanism 700 when the plates 706 are in their resting or closed position. Wings 702 may be configured such that when wings 702 are pinched or compressed to move the free ends of the wings 702 toward a longitudinal center of the clutch mechanism 700, the free ends of the plates 706 pivot radially outwardly to increase the distance between the plates 706 at their free ends. Movement of the wings 702 may be configured to cause a corresponding increase in distance between plates 706 at their free ends to surpass the diameter of ball 708, allowing tether 726 and associated balls 708 to translate through clutch mechanism 700, uninhibited by plates 706. Each wing 702 may include suture loop 704. Suture loop 704 may loop around wing 702, or a structure attached to wing 702 fit to receive suture loop 704, and extend proximally to be accessible to a surgeon, in a fashion substantially similar to other suture loops described herein. During tensioning of the tether 726, the suture loops 704 may be pulled proximally to compress or pinch the wings 702, and thus increase the distance between the free ends of plates 706. The tether 726 may be tensioned a desired amount, and the force on the wings 702 via suture loops 704 may be reduced so that the plates 706 move back to their resting configuration, inhibiting further movement of the tether 726 via contact between the balls 708 and the plates 706. Suture loops 704 may remain in place until valve 110 has been positioned and desired tension of tether 726 between anchor 210 and prosthetic valve 110 has been achieved. Suture loops 704 may then be released by pulling one end of suture loop 704 proximally until it vacates the patient's body. If it becomes desirable or necessary to adjust the tension of the tether 726 after the suture loops 704 have been removed from the patient, a separate tool may be introduced into the patient to compress or pinch wings 702, allowing for additional adjustment of the tension of the tether 726.



FIG. 32 illustrates valve 110 implanted in heart 234 with anchor 210 seated at or near apex 246 of heart 234. In the illustrated example, desired tension of tether 226 between valve 110 and anchor 210 has been achieved, and excess tether 226 extending proximally from valve 110 is cut and removed from the patient, leaving affixed valve 110 and properly tensioned tether 226 behind.


It should be understood that the ball and flap mechanism 300, the tabbed valve stem 400, the barbed valve stem 500, the guy-line tensioner 600, and the clutch mechanism 700 are all alternative mechanisms for allowing a tether of a prosthetic valve to be tensioned after the prosthetic valve is implanted in a transeptal or other minimally invasive delivery technique that preferably avoids any external puncture of the patient's chest. Each of these mechanisms may be provided on the prosthetic valve 110 without modification of the prosthetic valve 110, or may otherwise replace a portion of the prosthetic valve 110, such as the tether connecting portion 144 of the inner frame 140. Thus, although the prosthetic valve 110 is not described in detail in connection with each of these mechanisms, it should be understood that the mechanisms are intended for use with prosthetic valve 110 and anchor 210, as well as devices similar to prosthetic valve 110 and anchor 210.


According to one aspect of the disclosure, a prosthetic heart valve system comprises:


a prosthetic heart valve having an expandable stent and a prosthetic valve assembly disposed within the stent, the prosthetic valve assembly configured to allow blood to flow in a direction from an inflow end of the stent toward an outflow end of the stent and to substantially block blood from flowing from the outflow end of the stent toward the inflow end of the stent, the prosthetic heart valve including a tether connecting portion;


an anchor adapted to be disposed on or adjacent an epicardial surface of a heart of a patient; and


a tether having a distal end coupled to the anchor, the tether extending proximally from the anchor, the tether defining a protrusion having a width greater than portions of the tether adjacent the protrusion,


wherein the prosthetic heart valve is configured to be translated along the tether toward the distal end of the tether, the protrusion of the tether configured to engage the tether connecting portion to prevent proximal movement of the prosthetic heart valve relative to the tether; and/or


the protrusion is formed by a knot in the tether or a ball on the tether; and/or


the tether connecting portion includes a flap hingedly coupled to the tether connecting portion, the flap moveable between an open position in which the prosthetic heart valve may translate distally over the protrusion, and a closed position preventing proximal translation of the prosthetic heart valve over the protrusion relative to the tether; and/or


the flap is biased toward the closed position in the absence of applied force; and/or


the tether connecting portion includes a tube having two tabs pivotably coupled to the tube, the two tabs having a closed condition in which free ends of the two tabs extend radially inward of the tube; and/or


the two tabs each have a second end extending radially outward of the tube in the closed condition, the second ends configured to be compressed to pivot the free ends of the two tabs away from each other to transition the two tabs into an open condition; and/or


the two tabs may be biased to the closed condition in the absence of applied force; and/or


the two tabs may be formed integrally with the tube and shape set in the closed condition; and/or


the tether connecting portion includes a wing hingedly coupled to a plate, the wing having a closed condition in which the plate prevents the tether from translating relative to the prosthetic heart valve, wherein the wing is configured to receive a suture loop operable by a user to move the wing relative to the plate into an open condition in which the plate permits the tether to translate relative to the prosthetic heart valve; and/or


the suture loop may be removably coupled to the wing to separate the suture loop from the wing when the tether has a desired tension.


According to another embodiment of the disclosure, a prosthetic heart valve system comprises:


a prosthetic heart valve having an expandable stent and a prosthetic valve assembly disposed within the stent, the prosthetic valve assembly configured to allow blood to flow in a direction from an inflow end of the stent toward an outflow end of the stent and to substantially block blood from flowing from the outflow end of the stent toward the inflow end of the stent, the prosthetic heart valve including a tether connecting portion;


an anchor adapted to be disposed on or adjacent an epicardial surface of a heart of a patient; and


a tether having a distal end coupled to the anchor, the tether extending proximally from the anchor,


wherein the tether connecting portion includes a stem having a radially expanded condition, a radially collapsed condition, and a barb extending radially inward from the stem, the barb configured to pierce the tether upon transition of the stem from the radially expanded condition to the radially collapsed condition; and/or


the stem is configured to expand axially upon transitioning from the radially expanded condition to the radially collapsed condition; and/or


the prosthetic heart valve is configured to translate along the tether toward the distal end of the tether while the stem is in the radially expanded condition, and upon transitioning the stem from the radially expanded condition to the radially collapsed condition, the barb is configured to pierce the tether to prevent proximal translation of the prosthetic heart valve relative to the tether.


According to another embodiment of the disclosure, a prosthetic heart valve system comprises:


a prosthetic heart valve having an expandable stent and a prosthetic valve assembly disposed within the stent, the prosthetic valve assembly configured to allow blood to flow in a direction from an inflow end of the stent toward an outflow end of the stent and to substantially block blood from flowing from the outflow end of the stent toward the inflow end of the stent, the prosthetic heart valve including a tether connecting portion;


an anchor adapted to be disposed on or adjacent an epicardial surface of a heart of a patient;


a tether clip; and


a tether having a distal end coupled to the tether clip, a proximal end coupled to the tether connecting portion, a first intermediate tether portion looped around the anchor, and a second intermediate tether portion,


wherein the second intermediate tether portion may be threaded through an aperture in the tether clip, the tether clip configured to slide along the second intermediate tether portion to adjust a tension of the tether; and/or


the tether clip is configured to receive at least one suture loop operable by a user to slide the tether clip along the second intermediate tether portion.


According to another embodiment of the disclosure, a method of implanting a prosthetic heart valve comprises:


positioning an anchor adjacent a ventricular wall while a tether is coupled to and extends proximally from the anchor;


advancing the prosthetic heart valve distally along the tether while the anchor is positioned adjacent the ventricular wall;


deploying the prosthetic heart valve into a native valve annulus;


pulling the tether in a proximal direction to tension the tether; and


fixing the prosthetic heart valve to the tether while the tether is tensioned; and/or


the tether defines a protrusion having a width greater than portions of the tether adjacent the protrusion; and/or


the prosthetic heart valve is advanced distally along the tether, wings on a tether connecting portion of the prosthetic heart valve are compressed to allow the protrusion to pass through the tether connecting portion, and fixing the prosthetic heart valve to the tether includes releasing compression of the wings to prevent the protrusion from passing through the tether connecting portion; and/or


the prosthetic heart valve includes a tether connecting portion including a tube having two tabs pivotably coupled to the tube, the two tabs having a closed condition in which free ends of the two tabs extend radially inward of the tube, and as the prosthetic heart valve is advanced distally along the tether past the protrusion, the two tabs pivot to create clearance for the protrusion; and/or


the prosthetic heart valve includes a flap hingedly coupled to a tether connecting portion, and while pulling the tether in a proximal direction to tension the tether, the protrusion contacts the flap causing the flap to transition to an open condition allowing the protrusion to pass through the tether connecting portion; and/or


the proximal end of the tether is coupled to a tensioning mechanism while pulling the tether in the proximal direction; and/or


the method further comprises cutting the tether at a point proximal to a location on the tether where the tether is fixed to the prosthetic heart valve.


Although the invention herein has been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. For example, although embodiments of prosthetic valves are described herein in the context of prosthetic mitral valves, the disclosure may substantially similarly apply to prosthetic tricuspid valves, with or without modifications. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit and scope of the present invention as defined by the appended claims.

Claims
  • 1. A prosthetic heart valve system comprising: a prosthetic heart valve having an expandable frame assembly including an inner frame and an outer frame, and a prosthetic valve assembly disposed within the inner frame, the prosthetic valve assembly configured to allow blood to flow in a direction from an inflow end of the inner frame toward an outflow end of the inner frame and to block blood from flowing from the outflow end of the inner frame toward the inflow end of the inner frame, the inner frame including a tether connecting portion, wherein the inner frame includes a plurality of struts that extend radially inwardly toward a radial center of the inner frame, the tether connecting portion being coupled to the plurality of struts so that the tether connecting portion is positioned at the radial center of the inner frame;an anchor adapted to be disposed on or adjacent an epicardial surface of a heart of a patient; anda tether having a distal end fixedly coupled to the anchor, the tether extending proximally from the anchor, the tether defining a protrusion having a width greater than portions of the tether adjacent the protrusion,wherein the tether extends through the tether connection portion and is slidably coupled to the tether connection portion so that the prosthetic heart valve can translate along the tether toward the distal end of the tether while the distal end of the tether is fixedly coupled to the anchor, the protrusion of the tether configured to engage the tether connecting portion to prevent proximal movement of the prosthetic heart valve relative to the tether,wherein the tether connecting portion includes a flap hingedly coupled to the tether connecting portion, the flap moveable between an open position in which the prosthetic heart valve may translate distally over the protrusion, and a closed position preventing proximal translation of the prosthetic heart valve over the protrusion relative to the tether, the tether connection portion including a stem body that includes a rim, the flap abutting and contacting the rim in the closed position, the flap spaced away from the rim in the open position.
  • 2. The prosthetic heart valve system of claim 1, wherein the protrusion is formed by a knot in the tether or a ball on the tether.
  • 3. The prosthetic heart valve system of claim 1, wherein the flap is biased toward the closed position in the absence of applied force.
  • 4. The prosthetic heart valve system of claim 1, wherein in the closed position of the flap, the flap sits perpendicular to a central longitudinal axis of the tether connecting portion, and the tether extends through the flap.
  • 5. The prosthetic heart valve system of claim 4, wherein in the open position of the flap, the tether extends through the flap.
  • 6. The prosthetic heart valve system of claim 4, wherein the flap has a free end opposite an end of the flap that is hingedly coupled to the tether connecting portion, the free end having a circular circumference that is interrupted by a “U”-shaped recessed portion.
  • 7. The prosthetic heart valve system of claim 6, wherein two free arms of the flap define portions of the “U”-shaped recessed portion.
  • 8. The prosthetic heart valve system of claim 7, wherein the “U”-shaped recessed portion has a width defined between inner edges of the two free arms, the width of the “U”-shaped recessed portion being greater than a diameter of the tether, but smaller than a diameter of the protrusion.
  • 9. The prosthetic heart valve system of claim 6, wherein in the closed position of the flap, the tether extends through the “U”-shaped recessed portion of the flap.
  • 10. The prosthetic heart valve system of claim 9, wherein in the open position of the flap, the tether extends through the “U”-shape recessed portion of the flap.
  • 11. A method of implanting a prosthetic heart valve system, the method comprising: positioning an anchor adjacent a ventricular wall while a distal end of a tether is fixedly coupled to and extends proximally from the anchor, the anchor being adapted to be disposed on or adjacent an epicardial surface of a heart of a patient, the tether defining a protrusion having a width greater than portions of the tether adjacent the protrusion;advancing the prosthetic heart valve distally along the tether while the anchor is positioned adjacent the ventricular wall, the prosthetic heart valve having an expandable frame assembly including an inner frame and an outer frame, and a prosthetic valve assembly disposed within the inner frame, the prosthetic valve assembly configured to allow blood to flow in a direction from an inflow end of the inner frame toward an outflow end of the inner frame and to block blood from flowing from the outflow end of the inner frame toward the inflow end of the inner frame, the prosthetic heart valve including a tether connecting portion, wherein the inner frame includes a plurality of struts that extend radially inwardly toward a radial center of the inner frame, the tether connecting portion being coupled to the plurality of struts so that the tether connecting portion is positioned at the radial center of the inner frame;deploying the prosthetic heart valve into a native valve annulus;pulling the tether in a proximal direction to tension the tether, the tether extending through the tether connection portion and being slidably coupled to the tether connection portion so that the prosthetic heart valve can translate along the tether toward the distal end of the tether while the distal end of the tether is fixedly coupled to the anchor, the protrusion of the tether configured to engage the tether connecting portion to prevent proximal movement of the prosthetic heart valve relative to the tether; andfixing the prosthetic heart valve to the tether while the tether is tensioned,wherein the tether connecting portion includes a flap hingedly coupled to the tether connecting portion, the flap moveable between an open position in which the prosthetic heart valve may translate distally over the protrusion, and a closed position preventing proximal translation of the prosthetic heart valve over the protrusion relative to the tether, the tether connection portion including a stem body that includes a rim, the flap abutting and contacting the rim in the closed position, the flap spaced away from the rim in the open position.
  • 12. The method of claim 11, wherein while pulling the tether in the proximal direction to tension the tether, the protrusion contacts the flap causing the flap to transition to the open position allowing the protrusion to pass through the tether connecting portion.
  • 13. The method of claim 11, wherein a proximal end of the tether is coupled to a tensioning mechanism while pulling the tether in the proximal direction.
  • 14. The method of claim 11, further comprising cutting the tether at a point proximal to a location on the tether where the tether is fixed to the prosthetic heart valve.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims the benefit of the filing date of U.S. Provisional Patent Application No. 63/001,637 filed Mar. 30, 2020, the disclosure of which is hereby incorporated by reference.

US Referenced Citations (829)
Number Name Date Kind
2697008 Ross Dec 1954 A
3409013 Berry Nov 1968 A
3472230 Fogarty et al. Oct 1969 A
3476101 Ross Nov 1969 A
3548417 Kischer Dec 1970 A
3587115 Shiley Jun 1971 A
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3714671 Edwards et al. Feb 1973 A
3755823 Hancock Sep 1973 A
3976079 Samuels et al. Aug 1976 A
4003382 Dyke Jan 1977 A
4035849 Angell et al. Jul 1977 A
4056854 Boretos et al. Nov 1977 A
4073438 Meyer Feb 1978 A
4106129 Carpentier et al. Aug 1978 A
4222126 Boretos et al. Sep 1980 A
4265694 Boretos et al. May 1981 A
4297749 Davis et al. Nov 1981 A
4339831 Johnson Jul 1982 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4373216 Klawitter Feb 1983 A
4406022 Roy Sep 1983 A
4470157 Love Sep 1984 A
4490859 Black et al. Jan 1985 A
4535483 Klawitter et al. Aug 1985 A
4574803 Storz Mar 1986 A
4585705 Broderick et al. Apr 1986 A
4592340 Boyles Jun 1986 A
4605407 Black et al. Aug 1986 A
4612011 Kautzky Sep 1986 A
4626255 Reichart et al. Dec 1986 A
4638886 Marietta Jan 1987 A
4643732 Pietsch et al. Feb 1987 A
4655771 Wallsten Apr 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
4733665 Palmaz Mar 1988 A
4759758 Gabbay Jul 1988 A
4762128 Rosenbluth Aug 1988 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4787901 Baykut Nov 1988 A
4796629 Grayzel Jan 1989 A
4824180 Levrai Apr 1989 A
4829990 Thuroff et al. May 1989 A
4830117 Capasso May 1989 A
4851001 Taheri Jul 1989 A
4852223 McCreary Aug 1989 A
4856516 Hillstead Aug 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4922905 Strecker May 1990 A
4923013 De Gennaro May 1990 A
4960424 Grooters Oct 1990 A
4966604 Reiss Oct 1990 A
4979939 Shiber Dec 1990 A
4986830 Owens et al. Jan 1991 A
4994077 Dobben Feb 1991 A
4996873 Takeuchi Mar 1991 A
5007896 Shiber Apr 1991 A
5026366 Leckrone Jun 1991 A
5032128 Alonso Jul 1991 A
5035706 Giantureo et al. Jul 1991 A
5037434 Lane Aug 1991 A
5047041 Samuels Sep 1991 A
5059177 Towne et al. Oct 1991 A
5064435 Porter Nov 1991 A
5080668 Bolz et al. Jan 1992 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5163953 Vince Nov 1992 A
5167628 Boyles Dec 1992 A
5192297 Hull Mar 1993 A
5201880 Wright et al. Apr 1993 A
5266073 Wall Nov 1993 A
5282847 Trescony et al. Feb 1994 A
5295958 Shturman Mar 1994 A
5306296 Wright et al. Apr 1994 A
5332402 Teitelbaum Jul 1994 A
5336616 Livesey et al. Aug 1994 A
5344442 Deac Sep 1994 A
5360444 Kusuhara Nov 1994 A
5364407 Poll Nov 1994 A
5370685 Stevens Dec 1994 A
5397351 Pavcnik et al. Mar 1995 A
5411055 Kane May 1995 A
5411552 Andersen et al. May 1995 A
5415667 Frater May 1995 A
5443446 Shturman Aug 1995 A
5480424 Cox Jan 1996 A
5500014 Quijano et al. Mar 1996 A
5545209 Roberts et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5549665 Vesely et al. Aug 1996 A
5554184 Machiraju Sep 1996 A
5554185 Block et al. Sep 1996 A
5571175 Vanney et al. Nov 1996 A
5591185 Kilmer et al. Jan 1997 A
5607462 Imran Mar 1997 A
5607464 Trescony et al. Mar 1997 A
5609626 Quijano et al. Mar 1997 A
5639274 Fischell et al. Jun 1997 A
5662704 Gross Sep 1997 A
5665115 Cragg Sep 1997 A
5674279 Wright et al. Oct 1997 A
5697905 d'Ambrosio Dec 1997 A
5702368 Stevens et al. Dec 1997 A
5716417 Girard et al. Feb 1998 A
5728068 Leone et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5735842 Krueger et al. Apr 1998 A
5741333 Frid Apr 1998 A
5749890 Shaknovich May 1998 A
5756476 Epstein et al. May 1998 A
5769812 Stevens et al. Jun 1998 A
5792179 Sideris Aug 1998 A
5800508 Goicoechea et al. Sep 1998 A
5833673 Ockuly et al. Nov 1998 A
5840081 Andersen et al. Nov 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855602 Angell Jan 1999 A
5904697 Gifford, III et al. May 1999 A
5925063 Khosravi Jul 1999 A
5957949 Leonhardt et al. Sep 1999 A
5968052 Sullivan, III et al. Oct 1999 A
5968068 Dehdashtian et al. Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5993481 Marcade et al. Nov 1999 A
6027525 Suh et al. Feb 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6063112 Sgro May 2000 A
6077214 Mortier et al. Jun 2000 A
6099508 Bousquet Aug 2000 A
6132473 Williams et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6174327 Mertens et al. Jan 2001 B1
6183411 Mortier et al. Feb 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6217585 Houser et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6231602 Carpentier et al. May 2001 B1
6245102 Jayaraman Jun 2001 B1
6260552 Mortier et al. Jul 2001 B1
6261222 Schweich, Jr. et al. Jul 2001 B1
6264602 Mortier et al. Jul 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6312465 Griffin et al. Nov 2001 B1
6332893 Mortier et al. Dec 2001 B1
6350277 Kocur Feb 2002 B1
6358277 Duran Mar 2002 B1
6379372 Dehdashtian et al. Apr 2002 B1
6402679 Mortier et al. Jun 2002 B1
6402680 Mortier et al. Jun 2002 B2
6402781 Langberg et al. Jun 2002 B1
6406420 McCarthy et al. Jun 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468660 Ogle et al. Oct 2002 B2
6482228 Norred Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6537198 Vidlund et al. Mar 2003 B1
6540782 Snyders Apr 2003 B1
6569196 Vesely May 2003 B1
6575252 Reed Jun 2003 B2
6582462 Andersen et al. Jun 2003 B1
6605112 Moll et al. Aug 2003 B1
6616684 Vidlund et al. Sep 2003 B1
6622730 Ekvall et al. Sep 2003 B2
6623224 Schrader Sep 2003 B2
6629534 St. Goar et al. Oct 2003 B1
6629921 Schweich, Jr. et al. Oct 2003 B1
6648077 Hoffman Nov 2003 B2
6648921 Anderson et al. Nov 2003 B2
6652578 Bailey et al. Nov 2003 B2
6669724 Park et al. Dec 2003 B2
6706065 Langberg et al. Mar 2004 B2
6709456 Angberg et al. Mar 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6726715 Sutherland Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6740105 Yodfat et al. May 2004 B2
6746401 Panescu Jun 2004 B2
6746471 Mortier et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6764510 Vidlund et al. Jul 2004 B2
6797002 Spence et al. Sep 2004 B2
6810882 Langberg et al. Nov 2004 B2
6830584 Seguin Dec 2004 B1
6854668 Wancho et al. Feb 2005 B2
6855144 Lesh Feb 2005 B2
6858001 Aboul-Hosn Feb 2005 B1
6890353 Cohn et al. May 2005 B2
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6908424 Mortier et al. Jun 2005 B2
6908481 Cribier Jun 2005 B2
6936067 Buchanan Aug 2005 B2
6945996 Sedransk Sep 2005 B2
6955175 Stevens et al. Oct 2005 B2
6974476 McGuckin, Jr. et al. Dec 2005 B2
6976543 Fischer Dec 2005 B1
6997950 Chawla Feb 2006 B2
7018406 Seguin et al. Mar 2006 B2
7018408 Bailey et al. Mar 2006 B2
7044905 Vidlund et al. May 2006 B2
7060021 Wilk Jun 2006 B1
7077862 Vidlund et al. Jul 2006 B2
7087064 Hyde Aug 2006 B1
7100614 Stevens et al. Sep 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7108717 Freidberg Sep 2006 B2
7112219 Vidlund et al. Sep 2006 B2
7115141 Menz et al. Oct 2006 B2
7141064 Scott et al. Nov 2006 B2
7175656 Khairkhahan Feb 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7247134 Vidlund et al. Jul 2007 B2
7252682 Seguin Aug 2007 B2
7267686 DiMatteo et al. Sep 2007 B2
7275604 Wall Oct 2007 B1
7276078 Spenser et al. Oct 2007 B2
7276084 Yang et al. Oct 2007 B2
7316706 Bloom et al. Jan 2008 B2
7318278 Zhang et al. Jan 2008 B2
7326236 Andreas et al. Feb 2008 B2
7329278 Seguin et al. Feb 2008 B2
7331991 Kheradvar et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7374571 Pease et al. May 2008 B2
7377941 Rhee et al. May 2008 B2
7381210 Zarbatany et al. Jun 2008 B2
7381218 Schreck Jun 2008 B2
7393360 Spenser et al. Jul 2008 B2
7404824 Webler et al. Jul 2008 B1
7416554 Lam et al. Aug 2008 B2
7422072 Dade Sep 2008 B2
7429269 Schwammenthal et al. Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7445631 Salahieh et al. Nov 2008 B2
7462191 Spenser et al. Dec 2008 B2
7470285 Nugent et al. Dec 2008 B2
7500989 Solem et al. Mar 2009 B2
7503931 Kowalsky et al. Mar 2009 B2
7510572 Gabbay Mar 2009 B2
7510575 Spenser et al. Mar 2009 B2
7513908 Lattouf Apr 2009 B2
7524330 Berreklouw Apr 2009 B2
7527647 Spence May 2009 B2
7534260 Lattouf May 2009 B2
7556646 Yang et al. Jul 2009 B2
7579381 Dove Aug 2009 B2
7585321 Cribier Sep 2009 B2
7591847 Navia et al. Sep 2009 B2
7618446 Andersen et al. Nov 2009 B2
7618447 Case et al. Nov 2009 B2
7621948 Herrmann et al. Nov 2009 B2
7632304 Park Dec 2009 B2
7632308 Loulmet Dec 2009 B2
7635386 Gammie Dec 2009 B1
7674222 Nikolic et al. Mar 2010 B2
7674286 Alfieri et al. Mar 2010 B2
7695510 Bloom et al. Apr 2010 B2
7708775 Rowe et al. May 2010 B2
7748389 Salahieh et al. Jul 2010 B2
7766961 Patel et al. Aug 2010 B2
7789909 Andersen et al. Sep 2010 B2
7803168 Gifford et al. Sep 2010 B2
7803184 McGuckin, Jr. et al. Sep 2010 B2
7803185 Gabbay Sep 2010 B2
7806928 Rowe et al. Oct 2010 B2
7837727 Goetz et al. Nov 2010 B2
7854762 Speziali et al. Dec 2010 B2
7892281 Seguin et al. Feb 2011 B2
7896915 Guyenot et al. Mar 2011 B2
7901454 Kapadia et al. Mar 2011 B2
7927370 Webler et al. Apr 2011 B2
7931630 Nishtala et al. Apr 2011 B2
7942928 Webler et al. May 2011 B2
7955247 Levine et al. Jun 2011 B2
7955385 Crittenden Jun 2011 B2
7972378 Tabor et al. Jul 2011 B2
7988727 Santamore et al. Aug 2011 B2
7993394 Hariton et al. Aug 2011 B2
8007992 Tian et al. Aug 2011 B2
8029556 Rowe Oct 2011 B2
8043368 Crabtree Oct 2011 B2
8052749 Salahieh et al. Nov 2011 B2
8052750 Tuval et al. Nov 2011 B2
8052751 Aklog et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8062359 Marquez et al. Nov 2011 B2
8070802 Lamphere et al. Dec 2011 B2
8109996 Stacchino et al. Feb 2012 B2
8142495 Hasenkam et al. Mar 2012 B2
8152821 Gambale et al. Apr 2012 B2
8157810 Case et al. Apr 2012 B2
8167932 Bourang et al. May 2012 B2
8167934 Styrc et al. May 2012 B2
8187299 Goldfarb et al. May 2012 B2
8206439 Gomez Duran Jun 2012 B2
8216301 Bonhoeffer et al. Jul 2012 B2
8226711 Mortier et al. Jul 2012 B2
8236045 Benichou et al. Aug 2012 B2
8241274 Keogh et al. Aug 2012 B2
8252051 Chau et al. Aug 2012 B2
8303653 Bonhoeffer et al. Nov 2012 B2
8308796 Lashinski et al. Nov 2012 B2
8323334 Deem et al. Dec 2012 B2
8353955 Styrc et al. Jan 2013 B2
RE44075 Williamson et al. Mar 2013 E
8449599 Chau et al. May 2013 B2
8454656 Tuval Jun 2013 B2
8470028 Thornton et al. Jun 2013 B2
8480730 Maurer et al. Jul 2013 B2
8486138 Vesely Jul 2013 B2
8506623 Wilson et al. Aug 2013 B2
8506624 Vidlund et al. Aug 2013 B2
8578705 Sindano et al. Nov 2013 B2
8579913 Nielsen Nov 2013 B2
8579963 Tabor Nov 2013 B2
8591573 Barone Nov 2013 B2
8591576 Hasenkam et al. Nov 2013 B2
8597347 Maurer et al. Dec 2013 B2
8685086 Navia et al. Apr 2014 B2
8790394 Miller et al. Jul 2014 B2
8845717 Khairkhahan et al. Sep 2014 B2
8888843 Khairkhahan et al. Nov 2014 B2
8900214 Nance et al. Dec 2014 B2
8900295 Migliazza et al. Dec 2014 B2
8926696 Cabiri et al. Jan 2015 B2
8932342 McHugo et al. Jan 2015 B2
8932348 Solem et al. Jan 2015 B2
8945208 Jimenez et al. Feb 2015 B2
8956407 Macoviak et al. Feb 2015 B2
8979922 Jayasinghe et al. Mar 2015 B2
8986376 Solem Mar 2015 B2
9011522 Annest Apr 2015 B2
9023099 Duffy et al. May 2015 B2
9034032 McLean et al. May 2015 B2
9034033 McLean et al. May 2015 B2
9039757 McLean et al. May 2015 B2
9039759 Alkhatib et al. May 2015 B2
9078645 Conklin et al. Jul 2015 B2
9078749 Lutter et al. Jul 2015 B2
9084676 Chau et al. Jul 2015 B2
9095433 Lutter et al. Aug 2015 B2
9125742 Yoganathan et al. Sep 2015 B2
9149357 Seguin Oct 2015 B2
9161837 Kapadia Oct 2015 B2
9168137 Subramanian et al. Oct 2015 B2
9232995 Kovalsky et al. Jan 2016 B2
9232998 Wilson et al. Jan 2016 B2
9232999 Maurer et al. Jan 2016 B2
9241702 Maisano et al. Jan 2016 B2
9254192 Lutter et al. Feb 2016 B2
9265608 Miller et al. Feb 2016 B2
9289295 Aklog et al. Mar 2016 B2
9289297 Wilson et al. Mar 2016 B2
9345573 Nyuli et al. May 2016 B2
9364325 Alon et al. Jun 2016 B2
9480557 Pellegrini et al. Nov 2016 B2
9480559 Vidlund et al. Nov 2016 B2
9526611 Tegels et al. Dec 2016 B2
9597181 Christianson et al. Mar 2017 B2
9610159 Christianson et al. Apr 2017 B2
9675454 Vidlund et al. Jun 2017 B2
9730792 Lutter et al. Aug 2017 B2
9827092 Vidlund et al. Nov 2017 B2
9833315 Vidlund et al. Dec 2017 B2
9867700 Bakis et al. Jan 2018 B2
9883941 Hastings et al. Feb 2018 B2
9895221 Vidlund Feb 2018 B2
9986993 Vidlund et al. Jun 2018 B2
20010018611 Solem et al. Aug 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010025171 Mortier et al. Sep 2001 A1
20020010427 Scarfone et al. Jan 2002 A1
20020083562 Lerra Jul 2002 A1
20020101071 Ayliffe Aug 2002 A1
20020116054 Lundell et al. Aug 2002 A1
20020139056 Finnell Oct 2002 A1
20020151961 Lashinski et al. Oct 2002 A1
20020161377 Rabkin Oct 2002 A1
20020173842 Buchanan Nov 2002 A1
20020183827 Derus et al. Dec 2002 A1
20030010509 Hoffman Jan 2003 A1
20030036698 Kohler et al. Feb 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030078465 Pai Apr 2003 A1
20030078652 Sutherland Apr 2003 A1
20030100939 Yodfat et al. May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030105520 Alferness et al. Jun 2003 A1
20030120340 Liska et al. Jun 2003 A1
20030130731 Vidlund et al. Jul 2003 A1
20030149476 Damm et al. Aug 2003 A1
20030212454 Scott et al. Nov 2003 A1
20040039436 Spenser et al. Feb 2004 A1
20040049266 Anduiza et al. Mar 2004 A1
20040055606 Hendricksen et al. Mar 2004 A1
20040064014 Melvin et al. Apr 2004 A1
20040092858 Wilson et al. May 2004 A1
20040093075 Kuehne May 2004 A1
20040097865 Anderson et al. May 2004 A1
20040127983 Mortier et al. Jul 2004 A1
20040133263 Dusbabek et al. Jul 2004 A1
20040147958 Lam et al. Jul 2004 A1
20040152947 Schroeder et al. Aug 2004 A1
20040162610 Liska et al. Aug 2004 A1
20040163828 Silverstein et al. Aug 2004 A1
20040181239 Dorn et al. Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040260317 Bloom et al. Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20050004652 van der Burg et al. Jan 2005 A1
20050004666 Alfieri et al. Jan 2005 A1
20050075727 Wheatley Apr 2005 A1
20050080402 Santamore et al. Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050096498 Houser et al. May 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050107661 Lau et al. May 2005 A1
20050113798 Slater et al. May 2005 A1
20050113810 Houser et al. May 2005 A1
20050113811 Houser et al. May 2005 A1
20050119519 Girard et al. Jun 2005 A9
20050121206 Dolan Jun 2005 A1
20050125012 Houser et al. Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050148815 Mortier et al. Jul 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050203614 Forster et al. Sep 2005 A1
20050203615 Forster et al. Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050251209 Saadat et al. Nov 2005 A1
20050256567 Lim et al. Nov 2005 A1
20050283231 Haug et al. Dec 2005 A1
20050288763 Andreas et al. Dec 2005 A1
20050288766 Plain et al. Dec 2005 A1
20060004442 Spenser et al. Jan 2006 A1
20060025784 Starksen et al. Feb 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060042803 Gallaher Mar 2006 A1
20060047338 Jenson et al. Mar 2006 A1
20060052868 Mortier et al. Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060094983 Burbank et al. May 2006 A1
20060122633 To Jun 2006 A1
20060129025 Levine et al. Jun 2006 A1
20060142784 Kontos Jun 2006 A1
20060161040 McCarthy et al. Jul 2006 A1
20060161249 Realyvasquez et al. Jul 2006 A1
20060167541 Lattouf Jul 2006 A1
20060195134 Crittenden Aug 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060229708 Powell et al. Oct 2006 A1
20060229719 Marquez et al. Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060247491 Vidlund et al. Nov 2006 A1
20060252984 Rahdert et al. Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060276874 Wilson et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20060287716 Banbury et al. Dec 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20070005131 Taylor Jan 2007 A1
20070005231 Seguchi Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070016288 Gurskis et al. Jan 2007 A1
20070027535 Purdy et al. Feb 2007 A1
20070038291 Case et al. Feb 2007 A1
20070050020 Spence Mar 2007 A1
20070061010 Hauser et al. Mar 2007 A1
20070066863 Rafiee et al. Mar 2007 A1
20070073387 Forster et al. Mar 2007 A1
20070078297 Rafiee et al. Apr 2007 A1
20070083076 Lichtenstein Apr 2007 A1
20070083259 Bloom et al. Apr 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070093890 Eliasen et al. Apr 2007 A1
20070100439 Cangialosi et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070112425 Schaller et al. May 2007 A1
20070118151 Davidson May 2007 A1
20070118154 Crabtree May 2007 A1
20070118210 Pinchuk May 2007 A1
20070118213 Loulmet May 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070161846 Nikolic et al. Jul 2007 A1
20070162048 Quinn et al. Jul 2007 A1
20070162103 Case et al. Jul 2007 A1
20070168024 Khairkhahan Jul 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070185571 Kapadia et al. Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070215362 Rodgers Sep 2007 A1
20070221388 Johnson Sep 2007 A1
20070233239 Navia et al. Oct 2007 A1
20070239265 Birdsall Oct 2007 A1
20070244556 Rafiee Oct 2007 A1
20070256843 Pahila Nov 2007 A1
20070265658 Nelson et al. Nov 2007 A1
20070267202 Mariller Nov 2007 A1
20070270932 Headley et al. Nov 2007 A1
20070270943 Solem et al. Nov 2007 A1
20070293944 Spenser et al. Dec 2007 A1
20080009940 Cribier Jan 2008 A1
20080033543 Gurskis et al. Feb 2008 A1
20080057767 O'Rourke Mar 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080082163 Woo Apr 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080091264 Machold et al. Apr 2008 A1
20080114442 Mitchell et al. May 2008 A1
20080125861 Webler et al. May 2008 A1
20080147179 Cai et al. Jun 2008 A1
20080154355 Benichou et al. Jun 2008 A1
20080154356 Obermiller et al. Jun 2008 A1
20080161911 Revuelta et al. Jul 2008 A1
20080172035 Starksen et al. Jul 2008 A1
20080177381 Navia et al. Jul 2008 A1
20080183203 Fitzgerald et al. Jul 2008 A1
20080183273 Mesana et al. Jul 2008 A1
20080188928 Salahieh et al. Aug 2008 A1
20080208328 Antocci et al. Aug 2008 A1
20080208332 Amphere et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080243150 Starksen et al. Oct 2008 A1
20080243245 Thambar et al. Oct 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080288060 Kaye et al. Nov 2008 A1
20080293996 Evans et al. Nov 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090048668 Wilson et al. Feb 2009 A1
20090054968 Bonhoeffer et al. Feb 2009 A1
20090054974 McGuckin, Jr. et al. Feb 2009 A1
20090054976 Tuval et al. Feb 2009 A1
20090062908 Bonhoeffer et al. Mar 2009 A1
20090076598 Salahieh et al. Mar 2009 A1
20090082619 De Marchena Mar 2009 A1
20090088836 Bishop et al. Apr 2009 A1
20090099410 De Marchena Apr 2009 A1
20090112309 Jaramillo et al. Apr 2009 A1
20090131849 Maurer et al. May 2009 A1
20090132035 Roth et al. May 2009 A1
20090137861 Goldberg et al. May 2009 A1
20090138079 Tuval et al. May 2009 A1
20090157175 Benichou Jun 2009 A1
20090164005 Dove et al. Jun 2009 A1
20090171432 Von Segesser et al. Jul 2009 A1
20090171447 Von Segesser et al. Jul 2009 A1
20090171456 Kveen et al. Jul 2009 A1
20090173455 Hartley Jul 2009 A1
20090177266 Powell et al. Jul 2009 A1
20090192601 Rafiee et al. Jul 2009 A1
20090210052 Forster et al. Aug 2009 A1
20090216322 Le et al. Aug 2009 A1
20090222076 Figulla et al. Sep 2009 A1
20090224529 Gill Sep 2009 A1
20090234318 Loulmet et al. Sep 2009 A1
20090234435 Johnson et al. Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090240320 Tuval et al. Sep 2009 A1
20090248149 Gabbay Oct 2009 A1
20090276040 Rowe Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20090292262 Adams et al. Nov 2009 A1
20090319037 Rowe et al. Dec 2009 A1
20090326575 Galdonik et al. Dec 2009 A1
20100016958 St. Goar et al. Jan 2010 A1
20100021382 Dorshow et al. Jan 2010 A1
20100023117 Yoganathan et al. Jan 2010 A1
20100036479 Hill et al. Feb 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100082094 Quadri et al. Apr 2010 A1
20100161041 Maisano et al. Jun 2010 A1
20100168839 Braido et al. Jul 2010 A1
20100179641 Ryan et al. Jul 2010 A1
20100185277 Braido et al. Jul 2010 A1
20100185278 Schankereli Jul 2010 A1
20100191326 Alkhatib Jul 2010 A1
20100192402 Yamaguchi et al. Aug 2010 A1
20100204781 Alkhatib Aug 2010 A1
20100210899 Schankereli Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100234940 Dolan Sep 2010 A1
20100249489 Jarvik Sep 2010 A1
20100249923 Alkhatib et al. Sep 2010 A1
20100257701 Gammell Oct 2010 A1
20100280604 Zipory et al. Nov 2010 A1
20100286768 Alkhatib Nov 2010 A1
20100298755 McNamara et al. Nov 2010 A1
20100298931 Quadri et al. Nov 2010 A1
20110004296 Lutter et al. Jan 2011 A1
20110015616 Straubinger et al. Jan 2011 A1
20110015714 Atkinson Jan 2011 A1
20110015728 Jimenez et al. Jan 2011 A1
20110015729 Jimenez et al. Jan 2011 A1
20110029072 Gabbay Feb 2011 A1
20110046712 Melsheimer et al. Feb 2011 A1
20110054519 Neuss Mar 2011 A1
20110066231 Cartledge et al. Mar 2011 A1
20110066233 Thornton et al. Mar 2011 A1
20110112632 Chau et al. May 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110137408 Bergheim Jun 2011 A1
20110185476 Boisseau Aug 2011 A1
20110224655 Asirvatham et al. Sep 2011 A1
20110224678 Gabbay Sep 2011 A1
20110224728 Martin et al. Sep 2011 A1
20110224784 Quinn Sep 2011 A1
20110245911 Quill et al. Oct 2011 A1
20110251682 Murray, III et al. Oct 2011 A1
20110264191 Rothstein Oct 2011 A1
20110264206 Tabor Oct 2011 A1
20110288637 De Marchena Nov 2011 A1
20110301703 Glazier Dec 2011 A1
20110319988 Schankereli et al. Dec 2011 A1
20110319989 Ane et al. Dec 2011 A1
20120010694 Lutter et al. Jan 2012 A1
20120016468 Robin et al. Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120035703 Lutter et al. Feb 2012 A1
20120035713 Lutter et al. Feb 2012 A1
20120035722 Tuval Feb 2012 A1
20120053686 McNamara et al. Mar 2012 A1
20120059487 Cunanan et al. Mar 2012 A1
20120078347 Braido et al. Mar 2012 A1
20120083874 Dale et al. Apr 2012 A1
20120089171 Hastings et al. Apr 2012 A1
20120101571 Thambar et al. Apr 2012 A1
20120101572 Kovalsky et al. Apr 2012 A1
20120116351 Chomas et al. May 2012 A1
20120123529 Levi et al. May 2012 A1
20120158129 Duffy et al. Jun 2012 A1
20120165930 Gifford, III et al. Jun 2012 A1
20120179244 Schankereli et al. Jul 2012 A1
20120203336 Annest Aug 2012 A1
20120215303 Quadri et al. Aug 2012 A1
20120226348 Lane et al. Sep 2012 A1
20120239142 Liu et al. Sep 2012 A1
20120283824 Lutter et al. Nov 2012 A1
20120289945 Segermark Nov 2012 A1
20130030522 Rowe et al. Jan 2013 A1
20130053950 Rowe et al. Feb 2013 A1
20130059747 Mann et al. Mar 2013 A1
20130066341 Ketai et al. Mar 2013 A1
20130079873 Migliazza Mar 2013 A1
20130110228 Braido May 2013 A1
20130131788 Quadri et al. May 2013 A1
20130172978 Vidlund et al. Jul 2013 A1
20130184811 Rowe et al. Jul 2013 A1
20130190860 Sundt, III Jul 2013 A1
20130190861 Chau et al. Jul 2013 A1
20130197622 Mitra et al. Aug 2013 A1
20130226288 Goldwasser et al. Aug 2013 A1
20130231735 Deem et al. Sep 2013 A1
20130268064 Duffy Oct 2013 A1
20130274874 Hammer Oct 2013 A1
20130282101 Eidenschink et al. Oct 2013 A1
20130310928 Morriss et al. Nov 2013 A1
20130317603 McLean et al. Nov 2013 A1
20130325041 Annest et al. Dec 2013 A1
20130325110 Khalil et al. Dec 2013 A1
20130338752 Geusen et al. Dec 2013 A1
20140005767 Glazier et al. Jan 2014 A1
20140046433 Kovalsky Feb 2014 A1
20140081323 Hawkins Mar 2014 A1
20140094918 Vishnubholta et al. Apr 2014 A1
20140128963 Quill et al. May 2014 A1
20140142691 Pouletty May 2014 A1
20140163668 Rafiee Jun 2014 A1
20140194981 Menk et al. Jul 2014 A1
20140194983 Kovalsky et al. Jul 2014 A1
20140214159 Vidlund et al. Jul 2014 A1
20140222142 Kovalsky et al. Aug 2014 A1
20140243966 Garde et al. Aug 2014 A1
20140277419 Garde et al. Sep 2014 A1
20140296969 Tegels et al. Oct 2014 A1
20140296970 Ekvall et al. Oct 2014 A1
20140296971 Tegels et al. Oct 2014 A1
20140296972 Tegels et al. Oct 2014 A1
20140296975 Tegels et al. Oct 2014 A1
20140298621 Anfuso Oct 2014 A1
20140303718 Tegels et al. Oct 2014 A1
20140309732 Solem Oct 2014 A1
20140316516 Vidlund et al. Oct 2014 A1
20140316518 Kheradvar et al. Oct 2014 A1
20140324160 Benichou et al. Oct 2014 A1
20140324161 Tegels et al. Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140331475 Duffy et al. Nov 2014 A1
20140358224 Tegels et al. Dec 2014 A1
20140364942 Straubinger et al. Dec 2014 A1
20140364944 Lutter et al. Dec 2014 A1
20140379076 Vidlund et al. Dec 2014 A1
20150005874 Vidlund et al. Jan 2015 A1
20150011821 Gorman et al. Jan 2015 A1
20150025553 Del Nido et al. Jan 2015 A1
20150057705 Vidlund Feb 2015 A1
20150073542 Heldman Mar 2015 A1
20150073545 Braido Mar 2015 A1
20150094802 Buchbinder et al. Apr 2015 A1
20150105817 Marchand Apr 2015 A1
20150105856 Rowe et al. Apr 2015 A1
20150119936 Gilmore et al. Apr 2015 A1
20150119978 Tegels et al. Apr 2015 A1
20150127093 Hosmer et al. May 2015 A1
20150127096 Rowe et al. May 2015 A1
20150134050 Solem et al. May 2015 A1
20150142100 Morriss et al. May 2015 A1
20150142101 Coleman et al. May 2015 A1
20150142103 Vidlund May 2015 A1
20150142104 Braido May 2015 A1
20150173897 Raanani et al. Jun 2015 A1
20150196393 Vidlund et al. Jul 2015 A1
20150196688 James Jul 2015 A1
20150202044 Chau et al. Jul 2015 A1
20150216653 Freudenthal Aug 2015 A1
20150216660 Pintor Aug 2015 A1
20150223820 Olson Aug 2015 A1
20150223934 Vidlund et al. Aug 2015 A1
20150238312 Lashinski Aug 2015 A1
20150238729 Jenson et al. Aug 2015 A1
20150272731 Racchini et al. Oct 2015 A1
20150305860 Wang et al. Oct 2015 A1
20150305864 Quadri et al. Oct 2015 A1
20150305867 Liu et al. Oct 2015 A1
20150305868 Lutter et al. Oct 2015 A1
20150327995 Morin et al. Nov 2015 A1
20150328001 McLean Nov 2015 A1
20150335424 McLean Nov 2015 A1
20150335429 Morriss et al. Nov 2015 A1
20150342717 O'Donnell et al. Dec 2015 A1
20150351903 Morriss et al. Dec 2015 A1
20150351906 Hammer et al. Dec 2015 A1
20160000562 Siegel Jan 2016 A1
20160008131 Christianson et al. Jan 2016 A1
20160067042 Murad et al. Mar 2016 A1
20160074160 Christianson et al. Mar 2016 A1
20160106537 Christianson et al. Apr 2016 A1
20160113764 Sheahan Apr 2016 A1
20160143736 Vidlund et al. May 2016 A1
20160151155 Lutter et al. Jun 2016 A1
20160206280 Vidlund et al. Jul 2016 A1
20160242902 Morriss Aug 2016 A1
20160262879 Meiri et al. Sep 2016 A1
20160262881 Schankereli et al. Sep 2016 A1
20160278955 Liu et al. Sep 2016 A1
20160317290 Chau Nov 2016 A1
20160324635 Vidlund et al. Nov 2016 A1
20160331527 Vidlund et al. Nov 2016 A1
20160346086 Solem Dec 2016 A1
20160367365 Conklin Dec 2016 A1
20160367367 Maisano et al. Dec 2016 A1
20160367368 Vidlund et al. Dec 2016 A1
20170079790 Vidlund et al. Mar 2017 A1
20170100248 Tegels et al. Apr 2017 A1
20170128208 Christianson et al. May 2017 A1
20170181854 Christianson et al. Jun 2017 A1
20170196688 Christianson Jul 2017 A1
20170252153 Chau et al. Sep 2017 A1
20170258589 Pham et al. Sep 2017 A1
20170266001 Vidlund et al. Sep 2017 A1
20170281343 Christianson et al. Oct 2017 A1
20170312076 Lutter et al. Nov 2017 A1
20170312077 Vidlund et al. Nov 2017 A1
20170312078 Krivoruchko Nov 2017 A1
20170319333 Tegels et al. Nov 2017 A1
20180028314 Ekvall et al. Feb 2018 A1
20180078368 Vidlund et al. Mar 2018 A1
20180078370 Kovalsky et al. Mar 2018 A1
20180147055 Vidlund et al. May 2018 A1
20180153262 Shimizu Jun 2018 A1
20180193138 Vidlund Jul 2018 A1
20180263618 Vidlund et al. Sep 2018 A1
20180289473 Rajagopal Oct 2018 A1
20180289478 Quill Oct 2018 A1
20180289480 D'ambra Oct 2018 A1
20190117401 Cortez, Jr. Apr 2019 A1
20200022810 Christianson et al. Jan 2020 A1
20200187596 Krout Jun 2020 A1
20200318712 Aihara Oct 2020 A1
20210022855 Tegels Jan 2021 A1
20210030535 Liu Feb 2021 A1
20210046348 Arnold Feb 2021 A1
20210128298 Rengarajan May 2021 A1
20210169645 Dale Jun 2021 A1
20210177585 deHoog Jun 2021 A1
20210186687 Danielson Jun 2021 A1
20210298899 Huddleston Sep 2021 A1
20220008201 Passman Jan 2022 A1
20220023035 Rajagopal Jan 2022 A1
20220104941 Rajagopal Apr 2022 A1
Foreign Referenced Citations (148)
Number Date Country
1486161 Mar 2004 CN
1961845 May 2007 CN
2902226 May 2007 CN
101146484 Mar 2008 CN
101180010 May 2008 CN
101984938 Mar 2011 CN
102869317 Jan 2013 CN
102869318 Jan 2013 CN
102869321 Jan 2013 CN
103220993 Jul 2013 CN
102639179 Oct 2014 CN
2246526 Mar 1973 DE
19532846 Mar 1997 DE
19546692 Jun 1997 DE
19857887 Jul 2000 DE
19907646 Aug 2000 DE
10049812 Apr 2002 DE
10049813 Apr 2002 DE
10049815 Apr 2002 DE
102006052564 Dec 2007 DE
102006052710 May 2008 DE
102007043830 Apr 2009 DE
102007043831 Apr 2009 DE
0103546 Mar 1984 EP
1057460 Dec 2000 EP
1088529 Apr 2001 EP
1469797 Nov 2005 EP
2111800 Oct 2009 EP
2193762 Jun 2010 EP
2278944 Feb 2011 EP
2747707 Jul 2014 EP
2918248 Sep 2015 EP
2788217 Jul 2000 FR
2815844 May 2002 FR
2003505146 Feb 2003 JP
2005515836 Jun 2005 JP
2007509700 Apr 2007 JP
2008504078 Feb 2008 JP
2008541863 Nov 2008 JP
2009511229 Mar 2009 JP
2009514628 Apr 2009 JP
2009519783 May 2009 JP
2012504031 Feb 2012 JP
2012518465 Aug 2012 JP
2012519024 Aug 2012 JP
2013512765 Apr 2013 JP
2013525039 Jun 2013 JP
2013538086 Oct 2013 JP
2014513585 Jun 2014 JP
1017275 Aug 2002 NL
1271508 Nov 1986 SU
9217118 Oct 1992 WO
9301768 Feb 1993 WO
9829057 Jul 1998 WO
9940964 Aug 1999 WO
9947075 Sep 1999 WO
2000018333 Apr 2000 WO
2000030550 Jun 2000 WO
200041652 Jul 2000 WO
200047139 Aug 2000 WO
2001035878 May 2001 WO
0149213 Jul 2001 WO
200149213 Jul 2001 WO
0154625 Aug 2001 WO
2001054624 Aug 2001 WO
2001056512 Aug 2001 WO
2001061289 Aug 2001 WO
200176510 Oct 2001 WO
2001082840 Nov 2001 WO
2002004757 Jan 2002 WO
2002022054 Mar 2002 WO
2002028321 Apr 2002 WO
0236048 May 2002 WO
2002036048 May 2002 WO
2002041789 May 2002 WO
2002043620 Jun 2002 WO
2002049540 Jun 2002 WO
02076348 Oct 2002 WO
2003003943 Jan 2003 WO
2003030776 Apr 2003 WO
2003047468 Jun 2003 WO
2003049619 Jun 2003 WO
2004019825 Mar 2004 WO
2005102181 Nov 2005 WO
2006005082 Jan 2006 WO
2006014233 Feb 2006 WO
2006034008 Mar 2006 WO
2006064490 Jun 2006 WO
2006070372 Jul 2006 WO
2006105009 Oct 2006 WO
2006113906 Oct 2006 WO
2006127756 Nov 2006 WO
WO-2007056583 May 2007 WO
2007081412 Jul 2007 WO
2007100408 Sep 2007 WO
2008005405 Jan 2008 WO
2008035337 Mar 2008 WO
2008091515 Jul 2008 WO
2008125906 Oct 2008 WO
2008147964 Dec 2008 WO
2009024859 Feb 2009 WO
2009026563 Feb 2009 WO
2009045338 Apr 2009 WO
2009094500 Jul 2009 WO
2009132187 Oct 2009 WO
2010022138 Feb 2010 WO
2010090878 Aug 2010 WO
2010098857 Sep 2010 WO
2010121076 Oct 2010 WO
2011017440 Feb 2011 WO
2011022658 Feb 2011 WO
2011069048 Jun 2011 WO
2011072084 Jun 2011 WO
2011106735 Sep 2011 WO
2011109813 Sep 2011 WO
2011159342 Dec 2011 WO
2011163275 Dec 2011 WO
2012027487 Mar 2012 WO
2012036742 Mar 2012 WO
2012095116 Jul 2012 WO
2012177942 Dec 2012 WO
2013028387 Feb 2013 WO
2013045262 Apr 2013 WO
2013059747 Apr 2013 WO
2013096411 Jun 2013 WO
2013175468 Nov 2013 WO
2014071077 May 2014 WO
2014121280 Aug 2014 WO
2014144937 Sep 2014 WO
2014162306 Oct 2014 WO
2014189974 Nov 2014 WO
2015051430 Apr 2015 WO
2015058039 Apr 2015 WO
2015063580 May 2015 WO
2015065646 May 2015 WO
2015120122 Aug 2015 WO
2015138306 Sep 2015 WO
2015173609 Nov 2015 WO
2016112085 Jul 2016 WO
2016126942 Aug 2016 WO
2016168609 Oct 2016 WO
2016196933 Dec 2016 WO
2017096157 Jun 2017 WO
2017132008 Aug 2017 WO
2017218375 Dec 2017 WO
2018005779 Jan 2018 WO
2018013515 Jan 2018 WO
2019144121 Jul 2019 WO
Non-Patent Literature Citations (70)
Entry
US 9,155,620 B2, 10/2015, Gross et al. (withdrawn)
Dale, Theodore, et al., U.S. Appl. No. 17/112,169, filed Dec. 4, 2020, Titled “Braided Anchor For Mitral Valve”.
Robert C. Ashton Jr., “Development of an Intraluminal Device for the Treatment of Aortic Regurgitation: Prototype and In Vitro Testing System,” Journal of Thoracic and Cardiovascular Surgery, 1996, Issue/vol. 112, pp. 979-983.
Rosch, J. et al., “The Birth, Early Years and Future of Interventional Radiology,” J Vasc Interv Radiol., Jul. 2003, 4:841-853.
Ross, D. N., “Aortic Valve Surgery,” Guys Hospital, London, 1968, pp. 192-197.
Rousseau, E. P. M. et al., “A Mechanical Analysis of the Closed Hancock Heart Valve Prosthesis,” Journal of Biomechanics, 1998, 21(7):545-562.
Sabbah, A. N. et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Dec. 1989, Journal of Cardiac Surgery, 4(4):302-309.
Search Report for CN201680033815.7 dated Nov. 1, 2019, 3 pages.
Second Office Action for Chinese Application No. 201480037269.5, dated Nov. 6, 2017, 6 pages.
Selby, M.D., J. Bayne, “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems,” Radiology 1990; 176:535-538.
Serruys, P.W., et al., “Stenting of Coronary Arteries. Are we the Sorcerer's Apprentice?,” European Heart Journal (1989) 10, 774-782, pp. 37-45, Jun. 13, 1989.
Sigwart, U., “An Overview of Intravascular Stents: Old and New,” Chapter 48, Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815.
Third Office Action for Chinese Application No. 201480037269.5, dated Jun. 19, 2018, 8 pages.
Tofeig, M. et al., “Transcatheter Closure of a Mid-Muscular Ventricular Septal Defect with an Amplatzer VSD Occluder Device,” Heart, 1999, 81:438-440.
Uchida, Barry T., et al., “Modifications of Gianturco Expandable Wire Stents,” AJR:150, May 1988, Dec. 3, 1987, pp. 1185-1187.
US 9,155,620, Oct. 2015, Gross et al. (withdrawn)
Watt, A.H., et al. “Intravenous Adenosine in the Treatment of Supraventricular Tachycardia; a Dose-Ranging Study and Interaction with Dipyridamole,” British Journal of Clinical Pharmacology (1986), 21, pp. 227-230.
Webb, J. G. et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation, 2006, 113:842-850.
Wheatley, M.D., David J., “Valve Prostheses,” Rob & Smith's Operative Surgery, Fourth Edition, pp. 415-424, ButtenNorths 1986.
Yoganathan, A. P. et al., “The Current Status of Prosthetic Heart Valves,” In Polymetric Materials and Artificial Organs, Mar. 20, 1983, pp. 111-150, American Chemical Society.
“Shape Memory Alloys,” Retrieved from the Internet: <http:/webdocs.cs.ualberta.ca/˜database/MEMS/sma.html>, Feb. 5, 2016, 3 pages.
Al Zaibag, Muayed, et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenos's,” British Heart Journal, Jan. 1987, vol. 57, No. 1, pp. 51-53.
Al-Khaja, N. et al., “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, Jun. 30, 1989, 3:305-311.
Almagor, Y. et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits,” Journal of the American College of Cardiology, Nov. 1, 1990, 16(6):1310-1314.
Andersen, H. R., “History of Percutaneous Aortic Valve Prosthesis,” Herz, Aug. 2009, 34(5):343-346.
Andersen, H. R., “Transluminal catheter implanted prosthetic heart valves,” International Journal of Angiology, 1998, 7(2):102-106.
Australian Examination Report for Application No. 2016248314 dated Oct. 4, 2019, pp. 1-5.
Benchimol, A. et al., “Simultaneous Left Ventricular Echocardiography and Aortic Blood Velocity During Rapid Right Ventricular Pacing in Man,” The American Journal of the Medical Sciences, Jan.-Feb. 1977, 273(1):55-62.
Boudjemline, Y. et al., “Steps Toward the Percutaneous Replacement of Atrioventricular Valves: An Experimental Study,” Journal of the American College of Cardiology, Jul. 2005, 46(2):360-365.
Buckberg, G. et al., “Restoring Papillary Muscle Dimensions During Restoration In Dilated Hearts,” Interactive Cardiovascular and Thoracic Surgery, 2005, 4:475-477.
Chamberlain, G., “Ceramics Replace Body Parts,” Design News, Jun. 9, 1997, Issue 11, vol. 52, 5 pages.
Choo, S. J. et al., “Aortic Root Geometry: Pattern of Differences Between Leaflets and Sinuses of Valsava,” The Journal of Heart Valve Disease, Jul. 1999, 8:407-415.
Declaration of Malcolm J. R. Dalrymple-Hay, Nov. 9, 2012, pp. 1-11; with Curriculum Vitae, Oct. 4, 2012.
Dotter, C. T. et al., “Transluminal Treatment of Arteriosclerotic Obstruction. Description of a New Technic and a Preliminary Report of its Application,” Circulation, Nov. 1964, 30:654-670.
Drawbaugh, K., “Feature—Heart Surgeons Explore Minimally Invasive Methods,” Reuters Limited, Jul. 16, 1996, 3 pages.
Examination Report for European Application No. 14734333.9, dated Oct. 20, 2016, 6 pages.
Examination Report No. 1 for Australian Application No. 2014274056, dated Mar. 6, 2018, 4 pages.
Examination Report No. 2 for Australian Application No. 2014274056, dated May 9, 2018, 2 pages.
Extended European Search Report for European Application No. 18160595.7, dated Sep. 14, 2018, 7 pages.
Extended European Search Report including Written Opinion for Application No. EP20168419.8, dated Jul. 21, 2020, pp. 1-8.
Extended European Search Report including Written Opinion for EP20211930.1 dated Apr. 28, 2021; 8 pages.
Extended European Search Report issued in Appln. No. 21165656.6 dated Aug. 11, 2021 (2 pages).
G. M. Bernacca, et al., “Polyurethane Heart Valves: Fatigue Failure, Calcification, and Polyurethane Structure,” Journal of Biomedical Materials Research, Mar. 5, 1997, Issue 3, vol. 34, pp. 371-379.
Gray, H., The Aorta, Anatomy of the Human Body, 1918, Retrieved from the Internet <http://www.bartleby.com/107/142.html>, Dec. 10, 2012, 5 pages.
Gray, H., The Heart, Anatomy of the Human Body, 1918, Retrieved from the Internet <http:/education.yahoo.com/reference/gray/subjects/subject/138>, Aug. 10, 2012, 9 pages.
Greenhalgh, E. S., “Design and characterization of a biomimetic prosthetic aortic heart valve,” 1994, ProQuest Dissertations and Theses, Department of Fiber and Polymer Science, North Carolina State University at Raleigh, 159 pages.
H. R. Andersen et al., “Transluminal Implantation of Artificial Heart Valves: Description of a New Expandable Aortic Valve and Initial Results with Implantation by Catheter Technique in Closed Chest Pigs,” European Heart Journal, 1992, Issue 5, vol. 13, pp. 704-708.
Inoue, K. et al., “Clinical Application of Transvenous Mitral Commissurotomy by a New Balloon Catheter,” The Journal of Thoracic and Cardiovascular Surgery, 1984, 87:394-402.
International Search Report and Written Opinion for International Application No. PCT/US2014/040188, dated Nov. 17, 2014, 12 pages.
Invitation to Pay Additional Fees and Partial International Search Report for International Application No. PCT/US2014/040188, dated Sep. 8, 2014, 5 pages.
Japanese Office Action for Application No. 2020105100, dated Jun. 4, 2021, 4 pages.
Jin, X. Y. et al., “Aortic Root Geometry and Stentless Porcine Valve Competence,” Seminars in Thoracic and Cardiovascular Surgery, Oct. 1999, 11(4):145-150.
Knudsen, L. L. et al., “Catheter-implanted prosthetic heart valves. Transluminal catheter implantation of a new expandable artificial heart valve in the descending thoracic aorta in isolated vessels and closed chest pigs,” The International Journal of Artificial Organs, 1993, 16(5):253-262.
Kolata, G., “Device That Opens Clogged Arteries Gets a Failing Grade in a New Study,” New York Times [online], <http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-ar- teries-gets-a-faili . . . ,>, published Jan. 3, 1991, retrieved from the Internet on Feb. 5, 2016, 3 pages.
L. L. Knudsen et al., “Catheter-Implanted Prosthetic Heart Valves. Transluminal Catheter Implantation of a New Expandable Artificial Heart Valve in the Descending Thoracic Aorta in Isolated Vessels and Closed Chest Pigs,” International Journal ofArtificial Organs, 1993, Issue 5, vol. 16, pp. 253-262.
Lawrence, D. D., “Percutaneous Endovascular Graft: Experimental Evaluation,” Radiology, 1987, 163:357-360.
Lozonschi, L., et al. “Transapical mitral valved stent implantation: A survival series in swine,” The Journal of Thoracic and Cardiovascular Surgery, 140(2):422-426 (Aug. 2010) published online Mar. 12, 2010, 1 page.
Lutter, Georg, et al., Mitral valved stent implantation, European Journal of Cardio-Thoracic Surgery, 2010, vol. 38, pp. 350-355.
Ma, L. et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio-Thoracic Surgery, Aug. 2005, 28(2): 194-198.
Moazami, N. et al., “Transluminal aortic valve placement: A feasibility study with a newly designed collapsible aortic valve,” ASAIO Journal, Sep./ Oct. 1996, 42(5):M381-M385.
Notice of Reasons for Rejection for Japanese Application No. 2016-517032, dated Feb. 13, 2018, 5 pages.
Office Action for Chinese Application No. 201480037269.5, dated Dec. 23, 2016.
Office Action for U.S. Appl. No. 14/950,656, dated Apr. 22, 2016, 5 pages.
Orton, C., “Mitralseal: Hybrid Transcatheter Mitral Valve Replacement,” Symposium: Small Animal Proceedings, 2011, pp. 311-312.
Pavcnik, D. et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Radiology, 1992; 183:151-154.
Pavcnik, M.D., Ph.D., Dusan, et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology 1992; 183:151-154.
Porstmann, W. et al., “Der Verschluß des Ductus Arteriosus Persistens ohne Thorakotomie,” Thoraxchirurgie Vaskuläre Chirurgie, Band 15, Heft 2, Stuttgart, Apr. 1967, pp. 199-203.
Rashkind, W. J., “Creation of an Atrial Septal Defect Without Thoracotomy,” The Journal of the American Medical Association, Jun. 13, 1966, 196( 11 ): 173-174.
Rashkind, W. J., “Historical Aspects of Interventional Cardiology: Past, Present, Future,” Texas Heart Institute Journal, Dec. 1986, 13(4):363-367.
Reul, H. et al., “The Geomety of the Aortic Root in Health, at Valve Disease and After Valve Replacement,” J. Biomechanics, 1990, 23(2):181-191.
Related Publications (1)
Number Date Country
20210298894 A1 Sep 2021 US
Provisional Applications (1)
Number Date Country
63001637 Mar 2020 US